| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | serine-type endopeptidase activity | PCSK5 PRSS55 KLK14 KLK12 HTRA4 CFI F12 MST1 KLK8 C2 PLG KLK13 KLK1 | 3.05e-09 | 190 | 155 | 13 | GO:0004252 |
| GeneOntologyMolecularFunction | serine-type peptidase activity | PCSK5 PRSS55 KLK14 KLK12 HTRA4 CFI F12 MST1 KLK8 C2 PLG KLK13 KLK1 | 8.59e-09 | 207 | 155 | 13 | GO:0008236 |
| GeneOntologyMolecularFunction | serine hydrolase activity | PCSK5 PRSS55 KLK14 KLK12 HTRA4 CFI F12 MST1 KLK8 C2 PLG KLK13 KLK1 | 1.14e-08 | 212 | 155 | 13 | GO:0017171 |
| GeneOntologyMolecularFunction | endopeptidase activity | PCSK5 PRSS55 KLK14 KLK12 HTRA4 CFI F12 MST1 ADAMTS7 ADAMTS16 KLK8 ADAMTS15 C2 PLG KLK13 KLK1 ECE2 | 4.31e-08 | 430 | 155 | 17 | GO:0004175 |
| GeneOntologyMolecularFunction | complement component C3b binding | 1.65e-06 | 12 | 155 | 4 | GO:0001851 | |
| GeneOntologyMolecularFunction | complement binding | 4.49e-06 | 32 | 155 | 5 | GO:0001848 | |
| GeneOntologyMolecularFunction | peptidase activity | PCSK5 PRSS55 KLK14 KLK12 HTRA4 CFI F12 MST1 ADAMTS7 ADAMTS16 KLK8 ADAMTS15 C2 PLG KLK13 KLK1 ECE2 | 1.36e-05 | 654 | 155 | 17 | GO:0008233 |
| GeneOntologyMolecularFunction | opsonin binding | 3.89e-05 | 25 | 155 | 4 | GO:0001846 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | SELP NPHS1 TRIM25 ANK3 DSCAM CIP2A LAMB1 ITGAX SVEP1 ASAP1 TENM4 PTPRJ NRXN2 PTPRM TNKS1BP1 | 6.83e-05 | 599 | 155 | 15 | GO:0050839 |
| GeneOntologyMolecularFunction | glycosphingolipid binding | 1.24e-04 | 13 | 155 | 3 | GO:0043208 | |
| GeneOntologyMolecularFunction | spectrin binding | 1.35e-04 | 34 | 155 | 4 | GO:0030507 | |
| GeneOntologyMolecularFunction | immunoglobulin receptor binding | 5.51e-04 | 21 | 155 | 3 | GO:0034987 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 6.76e-04 | 188 | 155 | 7 | GO:0005201 | |
| GeneOntologyBiologicalProcess | complement activation | 6.58e-08 | 70 | 159 | 8 | GO:0006956 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion | SELE SELP CFH BOC NPHS1 TARM1 ANK3 DSCAM LAMB1 CR1 ITGAX PCDH20 SVEP1 ITPKB CFHR4 TYRO3 FAT2 SRPX2 TENM4 STXBP3 PTPRG NRXN2 PTPRM PDIA2 PLG NOTCH1 | 2.12e-07 | 1077 | 159 | 26 | GO:0098609 |
| GeneOntologyBiologicalProcess | complement activation, alternative pathway | 2.72e-07 | 19 | 159 | 5 | GO:0006957 | |
| GeneOntologyBiologicalProcess | immune complex clearance | 4.16e-07 | 9 | 159 | 4 | GO:0002434 | |
| GeneOntologyBiologicalProcess | negative regulation of humoral immune response mediated by circulating immunoglobulin | 1.60e-06 | 12 | 159 | 4 | GO:0002924 | |
| GeneOntologyBiologicalProcess | regulation of complement activation | 1.80e-06 | 27 | 159 | 5 | GO:0030449 | |
| GeneOntologyBiologicalProcess | blood vessel morphogenesis | CFH THSD7A LAMA1 ETV2 ITGAX ADGRA2 LDLR CRHR2 CFHR4 COL18A1 SRPX2 EGF PTPRJ PTPRM AHR SMO TAFA5 SEMA4A PLG NOTCH1 | 5.03e-06 | 817 | 159 | 20 | GO:0048514 |
| GeneOntologyBiologicalProcess | vasculature development | CFH PCSK5 THSD7A LAMA1 ETV2 ITGAX ADGRA2 LDLR SVEP1 CRHR2 CFHR4 COL18A1 SRPX2 EGF PTPRJ PTPRM AHR SMO TAFA5 SEMA4A PLG NOTCH1 | 5.46e-06 | 969 | 159 | 22 | GO:0001944 |
| GeneOntologyBiologicalProcess | negative regulation of immunoglobulin mediated immune response | 5.76e-06 | 16 | 159 | 4 | GO:0002890 | |
| GeneOntologyBiologicalProcess | negative regulation of B cell mediated immunity | 5.76e-06 | 16 | 159 | 4 | GO:0002713 | |
| GeneOntologyBiologicalProcess | regulation of humoral immune response | 6.78e-06 | 60 | 159 | 6 | GO:0002920 | |
| GeneOntologyBiologicalProcess | humoral immune response mediated by circulating immunoglobulin | 8.22e-06 | 62 | 159 | 6 | GO:0002455 | |
| GeneOntologyBiologicalProcess | activation of membrane attack complex | 8.84e-06 | 6 | 159 | 3 | GO:0001905 | |
| GeneOntologyBiologicalProcess | blood vessel development | CFH PCSK5 THSD7A LAMA1 ETV2 ITGAX ADGRA2 LDLR CRHR2 CFHR4 COL18A1 SRPX2 EGF PTPRJ PTPRM AHR SMO TAFA5 SEMA4A PLG NOTCH1 | 9.73e-06 | 929 | 159 | 21 | GO:0001568 |
| GeneOntologyBiologicalProcess | negative regulation of humoral immune response | 1.20e-05 | 19 | 159 | 4 | GO:0002921 | |
| GeneOntologyBiologicalProcess | regulation of complement activation, alternative pathway | 1.54e-05 | 7 | 159 | 3 | GO:0030451 | |
| GeneOntologyBiologicalProcess | positive regulation of locomotion | SELE SELP PCSK5 DSCAM LAMB1 ITGAX ADGRA2 COL18A1 SRPX2 NSMF EGF PTPRJ SMO ATM SEMA4A PLG NOTCH1 CPEB1 | 1.75e-05 | 742 | 159 | 18 | GO:0040017 |
| GeneOntologyBiologicalProcess | tube morphogenesis | CFH THSD7A LAMA1 ETV2 ITGAX ADGRA2 LDLR CRHR2 CFHR4 MST1 COL18A1 SRPX2 EGF PTPRJ PTPRM ADAMTS16 AHR SMO TAFA5 SEMA4A PLG CSMD1 NOTCH1 | 1.79e-05 | 1125 | 159 | 23 | GO:0035239 |
| GeneOntologyBiologicalProcess | complement activation, classical pathway | 2.18e-05 | 44 | 159 | 5 | GO:0006958 | |
| GeneOntologyBiologicalProcess | regulation of humoral immune response mediated by circulating immunoglobulin | 2.23e-05 | 22 | 159 | 4 | GO:0002923 | |
| GeneOntologyBiologicalProcess | contact inhibition | 2.45e-05 | 8 | 159 | 3 | GO:0060242 | |
| GeneOntologyBiologicalProcess | negative regulation of complement activation, classical pathway | 2.45e-05 | 8 | 159 | 3 | GO:0045959 | |
| GeneOntologyBiologicalProcess | positive regulation of cell migration | SELE SELP PCSK5 LAMB1 ITGAX ADGRA2 COL18A1 SRPX2 NSMF EGF PTPRJ SMO ATM SEMA4A PLG NOTCH1 CPEB1 | 2.54e-05 | 691 | 159 | 17 | GO:0030335 |
| GeneOntologyBiologicalProcess | regulation of locomotion | SELE SELP PCSK5 DSCAM LAMA1 MCC LAMB1 ITGAX ADGRA2 MST1 COL18A1 SRPX2 NSMF EGF PTPRG PTPRJ PTPRM SSX2IP SMO ATM TAFA5 SEMA4A PLG NOTCH1 CPEB1 | 2.94e-05 | 1327 | 159 | 25 | GO:0040012 |
| GeneOntologyBiologicalProcess | platelet activation | 3.16e-05 | 158 | 159 | 8 | GO:0030168 | |
| GeneOntologyBiologicalProcess | blood coagulation | 3.51e-05 | 260 | 159 | 10 | GO:0007596 | |
| GeneOntologyBiologicalProcess | detection of cell density | 3.65e-05 | 9 | 159 | 3 | GO:0060245 | |
| GeneOntologyBiologicalProcess | circulatory system development | CFH PCSK5 THSD7A ANK2 LAMA1 ETV2 ITGAX ADGRA2 LDLR SVEP1 CRHR2 CFHR4 COL18A1 SRPX2 TENM4 EGF PTPRJ PTPRM AHR SMO ATM TAFA5 SEMA4A PLG KLK1 NOTCH1 | 4.20e-05 | 1442 | 159 | 26 | GO:0072359 |
| GeneOntologyBiologicalProcess | coagulation | 4.25e-05 | 266 | 159 | 10 | GO:0050817 | |
| GeneOntologyBiologicalProcess | hemostasis | 4.53e-05 | 268 | 159 | 10 | GO:0007599 | |
| GeneOntologyBiologicalProcess | positive regulation of cell motility | SELE SELP PCSK5 LAMB1 ITGAX ADGRA2 COL18A1 SRPX2 NSMF EGF PTPRJ SMO ATM SEMA4A PLG NOTCH1 CPEB1 | 4.64e-05 | 725 | 159 | 17 | GO:2000147 |
| GeneOntologyBiologicalProcess | regulation of cell motility | SELE SELP PCSK5 LAMA1 MCC LAMB1 ITGAX ADGRA2 MST1 COL18A1 SRPX2 NSMF EGF PTPRG PTPRJ PTPRM SSX2IP SMO ATM TAFA5 SEMA4A PLG NOTCH1 CPEB1 | 4.66e-05 | 1280 | 159 | 24 | GO:2000145 |
| GeneOntologyBiologicalProcess | regulation of complement activation, classical pathway | 5.18e-05 | 10 | 159 | 3 | GO:0030450 | |
| GeneOntologyBiologicalProcess | inflammatory response | SELE SELP CFH TARM1 C2CD4B TICAM1 SNAP23 CR2 LDLR F12 CFHR4 TYRO3 TRIM45 FCGR2A SIGIRR NFX1 AHR SMO ATM KLK1 NOTCH1 | 5.35e-05 | 1043 | 159 | 21 | GO:0006954 |
| GeneOntologyBiologicalProcess | regulation of cell migration | SELE SELP PCSK5 LAMA1 MCC LAMB1 ITGAX ADGRA2 MST1 COL18A1 SRPX2 NSMF EGF PTPRG PTPRJ PTPRM SMO ATM TAFA5 SEMA4A PLG NOTCH1 CPEB1 | 5.62e-05 | 1211 | 159 | 23 | GO:0030334 |
| GeneOntologyBiologicalProcess | tube development | CFH PCSK5 THSD7A LAMA1 ETV2 ITGAX ADGRA2 LDLR CRHR2 CFHR4 MST1 COL18A1 SRPX2 EGF PTPRJ PTPRM SLC22A1 ADAMTS16 AHR SMO TAFA5 SEMA4A PLG CSMD1 NOTCH1 | 7.19e-05 | 1402 | 159 | 25 | GO:0035295 |
| GeneOntologyBiologicalProcess | angiogenesis | CFH THSD7A ITGAX ADGRA2 CRHR2 CFHR4 COL18A1 SRPX2 EGF PTPRJ PTPRM AHR TAFA5 SEMA4A PLG NOTCH1 | 1.20e-04 | 708 | 159 | 16 | GO:0001525 |
| GeneOntologyBiologicalProcess | regulation of complement-dependent cytotoxicity | 1.21e-04 | 13 | 159 | 3 | GO:1903659 | |
| GeneOntologyBiologicalProcess | epithelial cell migration | MCC ADGRA2 PLEKHG5 COL18A1 FAT2 SRPX2 EGF PTPRG PTPRM SEMA4A PLG NOTCH1 | 1.36e-04 | 432 | 159 | 12 | GO:0010631 |
| GeneOntologyBiologicalProcess | neuron development | CFH BOC ANK3 DSCAM LAMA1 LAMB1 PDZD7 TECTA CSMD3 ASAP1 CFHR4 TENM4 LLGL1 NSMF PTPRG FCGR2A PTPRM GORASP1 KLK8 SMO PRKCSH SEMA4A CFAP418 NOTCH1 CPEB1 | 1.41e-04 | 1463 | 159 | 25 | GO:0048666 |
| GeneOntologyBiologicalProcess | epithelium migration | MCC ADGRA2 PLEKHG5 COL18A1 FAT2 SRPX2 EGF PTPRG PTPRM SEMA4A PLG NOTCH1 | 1.45e-04 | 435 | 159 | 12 | GO:0090132 |
| GeneOntologyBiologicalProcess | neutrophil homeostasis | 1.48e-04 | 35 | 159 | 4 | GO:0001780 | |
| GeneOntologyBiologicalProcess | positive regulation of platelet activation | 1.54e-04 | 14 | 159 | 3 | GO:0010572 | |
| GeneOntologyBiologicalProcess | positive regulation of integrin-mediated signaling pathway | 1.54e-04 | 14 | 159 | 3 | GO:2001046 | |
| GeneOntologyBiologicalProcess | negative regulation of complement activation | 1.54e-04 | 14 | 159 | 3 | GO:0045916 | |
| GeneOntologyBiologicalProcess | negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 1.56e-04 | 66 | 159 | 5 | GO:0002823 | |
| GeneOntologyBiologicalProcess | tissue migration | MCC ADGRA2 PLEKHG5 COL18A1 FAT2 SRPX2 EGF PTPRG PTPRM SEMA4A PLG NOTCH1 | 1.65e-04 | 441 | 159 | 12 | GO:0090130 |
| GeneOntologyBiologicalProcess | regulation of response to external stimulus | SELE CFH C2CD4B TRIM25 DSCAM TICAM1 OAS3 CR1 ADGRA2 LDLR F12 CFHR4 MST1 TYRO3 TRIM45 PTPRJ FCGR2A SIGIRR AHR ATM TAFA5 PLG NOTCH1 | 1.94e-04 | 1316 | 159 | 23 | GO:0032101 |
| GeneOntologyBiologicalProcess | humoral immune response | 2.00e-04 | 321 | 159 | 10 | GO:0006959 | |
| GeneOntologyBiologicalProcess | negative regulation of adaptive immune response | 2.21e-04 | 71 | 159 | 5 | GO:0002820 | |
| GeneOntologyBiologicalProcess | complement-dependent cytotoxicity | 2.34e-04 | 16 | 159 | 3 | GO:0097278 | |
| GeneOntologyBiologicalProcess | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | CFH BACH2 CFI CR1 CR2 SVEP1 CFHR4 FCGR2A AHR C2 SEMA4A NOTCH1 | 2.53e-04 | 462 | 159 | 12 | GO:0002460 |
| GeneOntologyBiologicalProcess | regulation of epithelial cell migration | 3.47e-04 | 344 | 159 | 10 | GO:0010632 | |
| GeneOntologyBiologicalProcess | axon guidance | 3.78e-04 | 285 | 159 | 9 | GO:0007411 | |
| GeneOntologyBiologicalProcess | neuron projection guidance | 3.88e-04 | 286 | 159 | 9 | GO:0097485 | |
| GeneOntologyBiologicalProcess | homotypic cell-cell adhesion | 4.03e-04 | 124 | 159 | 6 | GO:0034109 | |
| GeneOntologyBiologicalProcess | nephron development | 4.10e-04 | 174 | 159 | 7 | GO:0072006 | |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | CFH NPHS1 THSD7A ANK2 DSCAM ETV2 ITGAX ADGRA2 CRHR2 CFHR4 COL18A1 SRPX2 TENM4 EGF PTPRJ PTPRM ADAMTS15 AHR SMO ATM TAFA5 SEMA4A PLG NOTCH1 | 4.32e-04 | 1483 | 159 | 24 | GO:0048646 |
| GeneOntologyBiologicalProcess | wound healing | SELP CFH F12 SVEP1 CFHR4 TYRO3 STXBP3 PTPRJ PDIA2 TAFA5 PLG FER1L5 | 4.53e-04 | 493 | 159 | 12 | GO:0042060 |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte mediated immunity | 4.57e-04 | 83 | 159 | 5 | GO:0002707 | |
| GeneOntologyBiologicalProcess | immunoglobulin mediated immune response | 4.89e-04 | 235 | 159 | 8 | GO:0016064 | |
| GeneOntologyBiologicalProcess | ameboidal-type cell migration | MCC ADGRA2 PLEKHG5 COL18A1 FAT2 SRPX2 EGF PTPRG PTPRM SMO SEMA4A PLG NOTCH1 | 5.46e-04 | 577 | 159 | 13 | GO:0001667 |
| GeneOntologyBiologicalProcess | camera-type eye photoreceptor cell differentiation | 5.50e-04 | 49 | 159 | 4 | GO:0060219 | |
| GeneOntologyBiologicalProcess | positive regulation of fibrinolysis | 5.82e-04 | 5 | 159 | 2 | GO:0051919 | |
| GeneOntologyBiologicalProcess | negative regulation of neutrophil apoptotic process | 5.82e-04 | 5 | 159 | 2 | GO:0033030 | |
| GeneOntologyBiologicalProcess | negative regulation of response to external stimulus | OAS3 CR1 LDLR F12 TYRO3 TRIM45 FCGR2A SIGIRR AHR TAFA5 PLG NOTCH1 | 6.01e-04 | 509 | 159 | 12 | GO:0032102 |
| GeneOntologyBiologicalProcess | B cell mediated immunity | 6.26e-04 | 244 | 159 | 8 | GO:0019724 | |
| GeneOntologyBiologicalProcess | retina morphogenesis in camera-type eye | 6.63e-04 | 90 | 159 | 5 | GO:0060042 | |
| GeneOntologyBiologicalProcess | endocytosis | SELE RABEPK AMN ANK2 ANK3 CUBN LDLR TYRO3 EGF PTPRJ FCGR2A MRC2 ARHGAP12 C2 SRPX FER1L5 | 6.73e-04 | 827 | 159 | 16 | GO:0006897 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | BOC ANK3 DSCAM LAMA1 LAMB1 PDZD7 TECTA LLGL1 NSMF PTPRM GORASP1 SMO SEMA4A CFAP418 NOTCH1 | 6.91e-04 | 748 | 159 | 15 | GO:0048667 |
| GeneOntologyBiologicalProcess | extracellular matrix organization | LAMA1 LAMB1 ADAMTSL3 COL18A1 COL24A1 ADAMTS7 ADAMTS16 ADAMTS15 PLG NOTCH1 | 7.07e-04 | 377 | 159 | 10 | GO:0030198 |
| GeneOntologyBiologicalProcess | regulation of integrin-mediated signaling pathway | 7.11e-04 | 23 | 159 | 3 | GO:2001044 | |
| GeneOntologyBiologicalProcess | extracellular structure organization | LAMA1 LAMB1 ADAMTSL3 COL18A1 COL24A1 ADAMTS7 ADAMTS16 ADAMTS15 PLG NOTCH1 | 7.22e-04 | 378 | 159 | 10 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | LAMA1 LAMB1 ADAMTSL3 COL18A1 COL24A1 ADAMTS7 ADAMTS16 ADAMTS15 PLG NOTCH1 | 7.37e-04 | 379 | 159 | 10 | GO:0045229 |
| GeneOntologyBiologicalProcess | cell activation | SELP CFH TARM1 TICAM1 SNAP23 CR1 CR2 ITGAX LDLR SVEP1 ITPKB CFHR4 TYRO3 STXBP3 PTPRJ FCGR2A AHR PDIA2 SMO ATM SEMA4A FER1L5 | 7.40e-04 | 1356 | 159 | 22 | GO:0001775 |
| GeneOntologyBiologicalProcess | platelet aggregation | 8.47e-04 | 95 | 159 | 5 | GO:0070527 | |
| GeneOntologyBiologicalProcess | kinin cascade | 8.68e-04 | 6 | 159 | 2 | GO:0002254 | |
| GeneOntologyBiologicalProcess | branching morphogenesis of an epithelial tube | 8.82e-04 | 198 | 159 | 7 | GO:0048754 | |
| GeneOntologyBiologicalProcess | photoreceptor cell differentiation | 8.88e-04 | 96 | 159 | 5 | GO:0046530 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated immunity | 8.88e-04 | 96 | 159 | 5 | GO:0002704 | |
| GeneOntologyBiologicalProcess | neuron projection development | BOC ANK3 DSCAM LAMA1 LAMB1 PDZD7 TECTA CSMD3 ASAP1 LLGL1 NSMF PTPRG FCGR2A PTPRM GORASP1 KLK8 SMO PRKCSH SEMA4A NOTCH1 CPEB1 | 8.97e-04 | 1285 | 159 | 21 | GO:0031175 |
| GeneOntologyBiologicalProcess | cardiac left ventricle morphogenesis | 9.13e-04 | 25 | 159 | 3 | GO:0003214 | |
| GeneOntologyBiologicalProcess | endothelial cell migration | 1.10e-03 | 331 | 159 | 9 | GO:0043542 | |
| GeneOntologyBiologicalProcess | activation of immune response | CFH TRIM25 TICAM1 OAS3 CFHR5 CFI CR1 CR2 SVEP1 CFHR4 TYRO3 PTPRJ C2 | 1.10e-03 | 623 | 159 | 13 | GO:0002253 |
| GeneOntologyBiologicalProcess | neural retina development | 1.17e-03 | 102 | 159 | 5 | GO:0003407 | |
| GeneOntologyBiologicalProcess | regulation of endothelial cell migration | 1.17e-03 | 269 | 159 | 8 | GO:0010594 | |
| GeneOntologyBiologicalProcess | growth involved in heart morphogenesis | 1.21e-03 | 7 | 159 | 2 | GO:0003241 | |
| GeneOntologyCellularComponent | extracellular matrix | NPHS1 FLG LAMA1 LAMB1 TECTA FREM3 ADAMTSL3 F12 SVEP1 MST1 COL18A1 COL24A1 SRPX2 FCGBP ADAMTS7 ADAMTS16 ADAMTS15 SRPX PLG | 5.70e-07 | 656 | 158 | 19 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | NPHS1 FLG LAMA1 LAMB1 TECTA FREM3 ADAMTSL3 F12 SVEP1 MST1 COL18A1 COL24A1 SRPX2 FCGBP ADAMTS7 ADAMTS16 ADAMTS15 SRPX PLG | 5.97e-07 | 658 | 158 | 19 | GO:0030312 |
| GeneOntologyCellularComponent | cell surface | SELE SELP CFH BOC RTP1 ANK3 CUBN CR1 CR2 ITGAX ADGRA2 LDLR CFHR4 TYRO3 SRPX2 PTPRJ FCGR2A ADAMTS7 MRC2 ADAMTS15 SRPX PLG NOTCH1 | 1.07e-05 | 1111 | 158 | 23 | GO:0009986 |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | SELP RABEPK MGAM TARM1 AMN TICAM1 UBR4 TMC6 SNAP23 CUBN CR1 ITGAX LDLR MTMR4 LLGL1 EGF ATP11B PTPRJ FCGR2A PLEKHM2 SMO ATM FER1L5 NOTCH1 ECE2 | 1.64e-05 | 1307 | 158 | 25 | GO:0030659 |
| GeneOntologyCellularComponent | tertiary granule membrane | 1.90e-05 | 73 | 158 | 6 | GO:0070821 | |
| GeneOntologyCellularComponent | vesicle membrane | SELP RABEPK MGAM TARM1 AMN TICAM1 UBR4 TMC6 SNAP23 CUBN CR1 ITGAX LDLR MTMR4 LLGL1 EGF ATP11B PTPRJ FCGR2A PLEKHM2 SMO ATM FER1L5 NOTCH1 ECE2 | 2.06e-05 | 1325 | 158 | 25 | GO:0012506 |
| GeneOntologyCellularComponent | secretory granule | SELP MGAM TARM1 UBR4 TMC6 PRSS55 SNAP23 KLK14 KLK12 CR1 ITGAX STXBP3 EGF ATP11B PTPRJ FCGR2A KLK8 PLG KLK13 KLK1 NOTCH1 | 2.67e-05 | 1014 | 158 | 21 | GO:0030141 |
| GeneOntologyCellularComponent | tertiary granule | 3.59e-05 | 164 | 158 | 8 | GO:0070820 | |
| GeneOntologyCellularComponent | secretory granule membrane | SELP MGAM TARM1 UBR4 TMC6 SNAP23 CR1 ITGAX ATP11B PTPRJ FCGR2A | 4.28e-05 | 329 | 158 | 11 | GO:0030667 |
| GeneOntologyCellularComponent | secretory vesicle | SELP MGAM TARM1 UBR4 TMC6 PRSS55 SNAP23 KLK14 KLK12 CR1 ITGAX STXBP3 EGF ATP11B PTPRJ FCGR2A KLK8 ATM PLG KLK13 FER1L5 KLK1 NOTCH1 | 6.41e-05 | 1246 | 158 | 23 | GO:0099503 |
| GeneOntologyCellularComponent | laminin-1 complex | 1.69e-04 | 3 | 158 | 2 | GO:0005606 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | NPHS1 FLG LAMA1 LAMB1 FREM3 F12 MST1 COL18A1 COL24A1 SRPX2 ADAMTS15 SRPX PLG | 2.01e-04 | 530 | 158 | 13 | GO:0062023 |
| GeneOntologyCellularComponent | cell-cell junction | NPHS1 ANK2 ANK3 LAMA1 SNAP23 PLEKHG5 FAT2 LLGL1 PTPRJ PTPRM SSX2IP TNKS1BP1 NOTCH1 | 5.68e-04 | 591 | 158 | 13 | GO:0005911 |
| GeneOntologyCellularComponent | specific granule membrane | 6.38e-04 | 91 | 158 | 5 | GO:0035579 | |
| GeneOntologyCellularComponent | adherens junction | 1.17e-03 | 212 | 158 | 7 | GO:0005912 | |
| GeneOntologyCellularComponent | ficolin-1-rich granule membrane | 1.17e-03 | 61 | 158 | 4 | GO:0101003 | |
| GeneOntologyCellularComponent | endosome | RABEPK CLEC18A AMN ANK2 CLEC18B TICAM1 UBR4 CLEC18C PHETA1 MON1A CUBN LDLR MTMR4 LLGL1 ATP11B FCGR2A PLEKHM2 SMO NOTCH1 | 1.33e-03 | 1167 | 158 | 19 | GO:0005768 |
| GeneOntologyCellularComponent | specific granule | 1.38e-03 | 160 | 158 | 6 | GO:0042581 | |
| GeneOntologyCellularComponent | symbiont cell surface | 1.54e-03 | 8 | 158 | 2 | GO:0106139 | |
| GeneOntologyCellularComponent | aryl hydrocarbon receptor complex | 1.54e-03 | 8 | 158 | 2 | GO:0034751 | |
| GeneOntologyCellularComponent | apical part of cell | TRPM6 MGAM AMN ANK2 CUBN LDLR KIAA1614 SPTBN5 STXBP3 SLC22A1 KLK1 NOTCH1 | 1.85e-03 | 592 | 158 | 12 | GO:0045177 |
| GeneOntologyCellularComponent | other organism part | 1.97e-03 | 9 | 158 | 2 | GO:0044217 | |
| GeneOntologyCellularComponent | external side of plasma membrane | 2.02e-03 | 519 | 158 | 11 | GO:0009897 | |
| GeneOntologyCellularComponent | basement membrane | 2.36e-03 | 122 | 158 | 5 | GO:0005604 | |
| GeneOntologyCellularComponent | laminin complex | 2.45e-03 | 10 | 158 | 2 | GO:0043256 | |
| GeneOntologyCellularComponent | endocytic vesicle | 2.64e-03 | 384 | 158 | 9 | GO:0030139 | |
| GeneOntologyCellularComponent | cell body fiber | 2.99e-03 | 11 | 158 | 2 | GO:0070852 | |
| GeneOntologyCellularComponent | clathrin-coated pit | 3.18e-03 | 80 | 158 | 4 | GO:0005905 | |
| MousePheno | decreased circulating complement protein level | 3.58e-06 | 4 | 136 | 3 | MP:0020216 | |
| MousePheno | abnormal circulating complement protein level | 1.76e-05 | 6 | 136 | 3 | MP:0010215 | |
| MousePheno | abnormal complement protein level | 7.25e-05 | 9 | 136 | 3 | MP:0011566 | |
| MousePheno | expanded mesangial matrix | 8.06e-05 | 46 | 136 | 5 | MP:0011353 | |
| MousePheno | artery occlusion | 9.40e-05 | 2 | 136 | 2 | MP:0006134 | |
| MousePheno | abnormal hepatic portal vein thrombosis | 9.40e-05 | 2 | 136 | 2 | MP:0031159 | |
| MousePheno | white pupil | 9.40e-05 | 2 | 136 | 2 | MP:0006242 | |
| MousePheno | decreased serum complement activity | 9.40e-05 | 2 | 136 | 2 | MP:0012553 | |
| MousePheno | decreased complement C5 level | 9.40e-05 | 2 | 136 | 2 | MP:0012609 | |
| MousePheno | abnormal complement C5 level | 9.40e-05 | 2 | 136 | 2 | MP:0012608 | |
| MousePheno | abnormal kidney thrombosis | 1.03e-04 | 10 | 136 | 3 | MP:0011507 | |
| MousePheno | abnormal mesangial matrix morphology | 1.33e-04 | 51 | 136 | 5 | MP:0011338 | |
| MousePheno | decreased IgG2a level | 1.66e-04 | 84 | 136 | 6 | MP:0008496 | |
| MousePheno | increased mesangial cell number | 1.69e-04 | 29 | 136 | 4 | MP:0011427 | |
| MousePheno | abnormal vascular development | PCSK5 UBR4 ETV2 CUBN ADGRA2 PLEKHG5 CRHR2 TRIM45 PTPRJ ADAMTS7 TONSL AHR SMO PLG NOTCH1 | 2.54e-04 | 542 | 136 | 15 | MP:0000259 |
| MousePheno | abnormal kidney venous thrombosis | 2.80e-04 | 3 | 136 | 2 | MP:0031161 | |
| MousePheno | increased susceptilbility to retina ischemic injury | 2.80e-04 | 3 | 136 | 2 | MP:0012049 | |
| MousePheno | abnormal hypersensitivity reaction | 2.99e-04 | 174 | 136 | 8 | MP:0002148 | |
| MousePheno | abnormal Bruch membrane morphology | 3.03e-04 | 14 | 136 | 3 | MP:0005239 | |
| MousePheno | retina detachment | 3.76e-04 | 15 | 136 | 3 | MP:0003099 | |
| Domain | Sushi | SELE SELP CFH CFHR5 CSMD2 CR1 CR2 CSMD3 SEZ6L2 SVEP1 CFHR4 SRPX2 C2 SRPX CSMD1 | 1.28e-19 | 52 | 157 | 15 | PF00084 |
| Domain | CCP | SELE SELP CFH CFHR5 CSMD2 CR1 CR2 CSMD3 SEZ6L2 SVEP1 CFHR4 SRPX2 C2 SRPX CSMD1 | 2.44e-19 | 54 | 157 | 15 | SM00032 |
| Domain | SUSHI | SELE SELP CFH CFHR5 CSMD2 CR1 CR2 CSMD3 SEZ6L2 SVEP1 CFHR4 SRPX2 C2 SRPX CSMD1 | 4.52e-19 | 56 | 157 | 15 | PS50923 |
| Domain | Sushi_SCR_CCP_dom | SELE SELP CFH CFHR5 CSMD2 CR1 CR2 CSMD3 SEZ6L2 SVEP1 CFHR4 SRPX2 C2 SRPX CSMD1 | 6.09e-19 | 57 | 157 | 15 | IPR000436 |
| Domain | EGF | SELE SELP PCSK5 CLEC18A CLEC18B LAMA1 CLEC18C LAMB1 CUBN TECTA LDLR F12 SVEP1 FAT2 FCGBP TENM4 EGF NRXN2 NOTCH1 | 1.14e-13 | 235 | 157 | 19 | SM00181 |
| Domain | EGF-like_dom | SELE SELP PCSK5 CLEC18A CLEC18B LAMA1 CLEC18C LAMB1 CUBN TECTA LDLR F12 SVEP1 FAT2 FCGBP TENM4 EGF NRXN2 NOTCH1 | 3.22e-13 | 249 | 157 | 19 | IPR000742 |
| Domain | Trypsin_dom | PRSS55 KLK14 KLK12 HTRA4 CFI F12 MST1 KLK8 C2 PLG KLK13 KLK1 | 4.33e-10 | 121 | 157 | 12 | IPR001254 |
| Domain | Trypsin | PRSS55 KLK14 KLK12 HTRA4 CFI F12 MST1 KLK8 C2 PLG KLK13 KLK1 | 4.33e-10 | 121 | 157 | 12 | PF00089 |
| Domain | EGF_1 | SELE SELP CLEC18A CLEC18B LAMA1 CLEC18C LAMB1 CUBN LDLR F12 SVEP1 FAT2 TENM4 EGF NRXN2 NOTCH1 | 4.85e-10 | 255 | 157 | 16 | PS00022 |
| Domain | Peptidase_S1_PA | PRSS55 KLK14 KLK12 HTRA4 CFI F12 MST1 KLK8 C2 PLG KLK13 KLK1 | 5.25e-10 | 123 | 157 | 12 | IPR009003 |
| Domain | EGF-like_CS | SELE SELP CLEC18A CLEC18B LAMA1 CLEC18C LAMB1 CUBN LDLR F12 SVEP1 FAT2 TENM4 EGF NRXN2 NOTCH1 | 6.81e-10 | 261 | 157 | 16 | IPR013032 |
| Domain | EGF_2 | SELE SELP CLEC18A CLEC18B LAMA1 CLEC18C LAMB1 CUBN LDLR F12 SVEP1 FAT2 TENM4 EGF NRXN2 NOTCH1 | 8.50e-10 | 265 | 157 | 16 | PS01186 |
| Domain | Peptidase_S1A | 2.90e-09 | 113 | 157 | 11 | IPR001314 | |
| Domain | TRYPSIN_DOM | 3.49e-09 | 115 | 157 | 11 | PS50240 | |
| Domain | Tryp_SPc | 4.20e-09 | 117 | 157 | 11 | SM00020 | |
| Domain | TRYPSIN_SER | 4.24e-09 | 90 | 157 | 10 | IPR033116 | |
| Domain | EGF_3 | SELE SELP CLEC18A CLEC18B CLEC18C CUBN LDLR F12 SVEP1 FAT2 TENM4 EGF NRXN2 NOTCH1 | 1.20e-08 | 235 | 157 | 14 | PS50026 |
| Domain | TRYPSIN_HIS | 1.59e-08 | 103 | 157 | 10 | IPR018114 | |
| Domain | TRYPSIN_SER | 2.11e-08 | 106 | 157 | 10 | PS00135 | |
| Domain | TRYPSIN_HIS | 2.31e-08 | 107 | 157 | 10 | PS00134 | |
| Domain | EGF | 1.10e-07 | 126 | 157 | 10 | PF00008 | |
| Domain | HYR | 5.83e-07 | 3 | 157 | 3 | PS50825 | |
| Domain | HYR_dom | 5.83e-07 | 3 | 157 | 3 | IPR003410 | |
| Domain | HYR | 5.83e-07 | 3 | 157 | 3 | PF02494 | |
| Domain | C-type_lectin_CS | 1.51e-06 | 43 | 157 | 6 | IPR018378 | |
| Domain | CUB | 3.33e-06 | 49 | 157 | 6 | PF00431 | |
| Domain | CUB | 3.75e-06 | 50 | 157 | 6 | SM00042 | |
| Domain | - | 4.74e-06 | 52 | 157 | 6 | 2.60.120.290 | |
| Domain | CUB | 5.31e-06 | 53 | 157 | 6 | PS01180 | |
| Domain | Growth_fac_rcpt_ | 6.93e-06 | 156 | 157 | 9 | IPR009030 | |
| Domain | CUB_dom | 8.17e-06 | 57 | 157 | 6 | IPR000859 | |
| Domain | ConA-like_dom | TRIM25 NBEAL1 LAMA1 FSD2 SVEP1 COL18A1 COL24A1 FAT2 NRXN2 PTPRM | 1.67e-05 | 219 | 157 | 10 | IPR013320 |
| Domain | PLAC | 1.69e-05 | 19 | 157 | 4 | PS50900 | |
| Domain | PLAC | 1.69e-05 | 19 | 157 | 4 | IPR010909 | |
| Domain | - | 1.77e-05 | 97 | 157 | 7 | 3.10.100.10 | |
| Domain | C-type_lectin-like/link | 2.02e-05 | 99 | 157 | 7 | IPR016186 | |
| Domain | CTDL_fold | 3.35e-05 | 107 | 157 | 7 | IPR016187 | |
| Domain | Peptidase_M12B_ADAM-TS | 4.48e-05 | 24 | 157 | 4 | IPR013273 | |
| Domain | C_TYPE_LECTIN_1 | 5.77e-05 | 80 | 157 | 6 | PS00615 | |
| Domain | fn3 | 6.90e-05 | 162 | 157 | 8 | PF00041 | |
| Domain | Lectin_C | 7.59e-05 | 84 | 157 | 6 | PF00059 | |
| Domain | CLECT | 7.59e-05 | 84 | 157 | 6 | SM00034 | |
| Domain | EGF_CA | 7.74e-05 | 122 | 157 | 7 | SM00179 | |
| Domain | C_TYPE_LECTIN_2 | 8.11e-05 | 85 | 157 | 6 | PS50041 | |
| Domain | EGF-like_Ca-bd_dom | 8.58e-05 | 124 | 157 | 7 | IPR001881 | |
| Domain | C-type_lectin-like | 8.66e-05 | 86 | 157 | 6 | IPR001304 | |
| Domain | Laminin_G | 1.26e-04 | 58 | 157 | 5 | IPR001791 | |
| Domain | Kringle-like | 1.44e-04 | 32 | 157 | 4 | IPR013806 | |
| Domain | - | 1.50e-04 | 95 | 157 | 6 | 2.60.120.200 | |
| Domain | FN3 | 1.73e-04 | 185 | 157 | 8 | SM00060 | |
| Domain | zf-RING_UBOX | 1.83e-04 | 34 | 157 | 4 | PF13445 | |
| Domain | Znf-RING_LisH | 1.83e-04 | 34 | 157 | 4 | IPR027370 | |
| Domain | TSP_1 | 1.87e-04 | 63 | 157 | 5 | PF00090 | |
| Domain | PLAC | 1.98e-04 | 14 | 157 | 3 | PF08686 | |
| Domain | TILa_dom | 2.09e-04 | 3 | 157 | 2 | IPR025615 | |
| Domain | DUF4174 | 2.09e-04 | 3 | 157 | 2 | PF13778 | |
| Domain | TECPR | 2.09e-04 | 3 | 157 | 2 | SM00706 | |
| Domain | Selectin_superfamily | 2.09e-04 | 3 | 157 | 2 | IPR002396 | |
| Domain | DUF4174 | 2.09e-04 | 3 | 157 | 2 | IPR025232 | |
| Domain | TILa | 2.09e-04 | 3 | 157 | 2 | PF12714 | |
| Domain | Beta-propeller_rpt_TECPR | 2.09e-04 | 3 | 157 | 2 | IPR006624 | |
| Domain | TSP1 | 2.17e-04 | 65 | 157 | 5 | SM00209 | |
| Domain | TSP1_rpt | 2.17e-04 | 65 | 157 | 5 | IPR000884 | |
| Domain | TSP1 | 2.17e-04 | 65 | 157 | 5 | PS50092 | |
| Domain | CAP | 2.46e-04 | 15 | 157 | 3 | PF00188 | |
| Domain | SCP | 2.46e-04 | 15 | 157 | 3 | SM00198 | |
| Domain | Allrgn_V5/Tpx1 | 2.46e-04 | 15 | 157 | 3 | IPR001283 | |
| Domain | - | 2.46e-04 | 15 | 157 | 3 | 3.40.33.10 | |
| Domain | CAP_domain | 2.46e-04 | 15 | 157 | 3 | IPR014044 | |
| Domain | LAM_G_DOMAIN | 2.84e-04 | 38 | 157 | 4 | PS50025 | |
| Domain | FN3 | 2.85e-04 | 199 | 157 | 8 | PS50853 | |
| Domain | Laminin_G_2 | 3.47e-04 | 40 | 157 | 4 | PF02210 | |
| Domain | Kringle_CS | 3.63e-04 | 17 | 157 | 3 | IPR018056 | |
| Domain | KRINGLE_1 | 3.63e-04 | 17 | 157 | 3 | PS00021 | |
| Domain | KR | 3.63e-04 | 17 | 157 | 3 | SM00130 | |
| Domain | Kringle | 3.63e-04 | 17 | 157 | 3 | IPR000001 | |
| Domain | KRINGLE_2 | 3.63e-04 | 17 | 157 | 3 | PS50070 | |
| Domain | Kringle | 3.63e-04 | 17 | 157 | 3 | PF00051 | |
| Domain | FN3_dom | 3.95e-04 | 209 | 157 | 8 | IPR003961 | |
| Domain | DysFC | 4.17e-04 | 4 | 157 | 2 | SM00694 | |
| Domain | DysFN | 4.17e-04 | 4 | 157 | 2 | SM00693 | |
| Domain | Peroxin/Ferlin | 4.17e-04 | 4 | 157 | 2 | IPR006614 | |
| Domain | LamG | 5.02e-04 | 44 | 157 | 4 | SM00282 | |
| Domain | - | 5.96e-04 | 46 | 157 | 4 | 4.10.400.10 | |
| Domain | PAN_AP | 6.91e-04 | 5 | 157 | 2 | SM00473 | |
| Domain | LDrepeatLR_classA_rpt | 7.59e-04 | 49 | 157 | 4 | IPR002172 | |
| Domain | LDLa | 7.59e-04 | 49 | 157 | 4 | SM00192 | |
| Domain | EGF_CA | 7.93e-04 | 86 | 157 | 5 | PF07645 | |
| Domain | ADAM_spacer1 | 9.12e-04 | 23 | 157 | 3 | IPR010294 | |
| Domain | ADAM_spacer1 | 9.12e-04 | 23 | 157 | 3 | PF05986 | |
| Domain | Ig-like_fold | BOC NPHS1 TARM1 DSCAM FSD2 ADAMTSL3 ADGRA2 TYRO3 TRIM45 PTPRG PTPRJ FCGR2A PTPRM SIGIRR SEMA4A | 9.17e-04 | 706 | 157 | 15 | IPR013783 |
| Domain | ig | 1.14e-03 | 190 | 157 | 7 | PF00047 | |
| Domain | Immunoglobulin | 1.14e-03 | 190 | 157 | 7 | IPR013151 | |
| Domain | Ephrin_rec_like | 1.17e-03 | 25 | 157 | 3 | SM01411 | |
| Domain | Tyr-kin_ephrin_A/B_rcpt-like | 1.17e-03 | 25 | 157 | 3 | IPR011641 | |
| Domain | PAS | 1.17e-03 | 25 | 157 | 3 | PF00989 | |
| Domain | PAS_fold | 1.17e-03 | 25 | 157 | 3 | IPR013767 | |
| Domain | Galactose-bd-like | 1.18e-03 | 94 | 157 | 5 | IPR008979 | |
| Domain | EGF_Ca-bd_CS | 1.36e-03 | 97 | 157 | 5 | IPR018097 | |
| Domain | Pan_app | 1.43e-03 | 7 | 157 | 2 | IPR003609 | |
| Pathway | WP_COMPLEMENT_SYSTEM | 4.60e-11 | 96 | 125 | 12 | M39581 | |
| Pathway | WP_COMPLEMENT_AND_COAGULATION_CASCADES | 7.52e-07 | 58 | 125 | 7 | M39649 | |
| Pathway | WP_DENGUE2_INTERACTIONS_WITH_COMPLEMENT_AND_COAGULATION_CASCADES | 8.47e-07 | 59 | 125 | 7 | M48343 | |
| Pathway | KEGG_COMPLEMENT_AND_COAGULATION_CASCADES | 2.49e-06 | 69 | 125 | 7 | M16894 | |
| Pathway | WP_COMPLEMENT_SYSTEM_IN_NEURONAL_DEVELOPMENT_AND_PLASTICITY | 4.45e-06 | 106 | 125 | 8 | M42535 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ALTERNATIVE_PATHWAY_OF_COMPLEMENT_CASCADE_C3B_BREAKDOWN | 6.72e-06 | 5 | 125 | 3 | M47875 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_COMPLEMENT_CASCADE_CFHR | 1.34e-05 | 6 | 125 | 3 | M47880 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 2.29e-05 | 39 | 125 | 5 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 2.29e-05 | 39 | 125 | 5 | MM15165 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 3.01e-05 | 68 | 125 | 6 | M27303 | |
| Pathway | REACTOME_COMPLEMENT_CASCADE | 7.22e-05 | 115 | 125 | 7 | M19752 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 4.14e-04 | 109 | 125 | 6 | MM15164 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 4.57e-04 | 111 | 125 | 6 | M27416 | |
| Pubmed | 2.32e-09 | 5 | 163 | 4 | 20962256 | ||
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | CFH PCSK5 LAMA1 LAMB1 CFI LDLR SVEP1 CFHR4 COL18A1 SRPX2 ADAMTS7 C2 | 2.48e-09 | 248 | 163 | 12 | 24006456 |
| Pubmed | Human tissue kallikreins: physiologic roles and applications in cancer. | 2.65e-09 | 13 | 163 | 5 | 15192120 | |
| Pubmed | 3.71e-09 | 257 | 163 | 12 | 16335952 | ||
| Pubmed | 4.11e-09 | 14 | 163 | 5 | 25666037 | ||
| Pubmed | 6.15e-09 | 15 | 163 | 5 | 15203212 | ||
| Pubmed | 6.15e-09 | 15 | 163 | 5 | 16800723 | ||
| Pubmed | A comprehensive nomenclature for serine proteases with homology to tissue kallikreins. | 6.15e-09 | 15 | 163 | 5 | 16800724 | |
| Pubmed | 8.91e-09 | 16 | 163 | 5 | 20424135 | ||
| Pubmed | Genetic influences on the end-stage effector phase of arthritis. | 8.91e-09 | 16 | 163 | 5 | 11489951 | |
| Pubmed | Genetic organization of complement receptor-related genes in the mouse. | 3.21e-08 | 8 | 163 | 4 | 2564419 | |
| Pubmed | 5.75e-08 | 9 | 163 | 4 | 20059470 | ||
| Pubmed | 6.63e-08 | 75 | 163 | 7 | 20637190 | ||
| Pubmed | Genetic contributions of nonautoimmune SWR mice toward lupus nephritis. | 8.41e-08 | 24 | 163 | 5 | 11739537 | |
| Pubmed | Organization and evolution of the glandular kallikrein locus in Mus musculus. | 9.55e-08 | 10 | 163 | 4 | 12437987 | |
| Pubmed | 9.55e-08 | 10 | 163 | 4 | 19558318 | ||
| Pubmed | Influence of the apoA-II gene locus on HDL levels and fatty streak development in mice. | 9.55e-08 | 10 | 163 | 4 | 8422330 | |
| Pubmed | 1.01e-07 | 3 | 163 | 3 | 19828624 | ||
| Pubmed | 1.01e-07 | 3 | 163 | 3 | 18202746 | ||
| Pubmed | 1.01e-07 | 3 | 163 | 3 | 16336259 | ||
| Pubmed | Endosomal TLR3 co-receptor CLEC18A enhances host immune response to viral infection. | 1.01e-07 | 3 | 163 | 3 | 33603190 | |
| Pubmed | 1.01e-07 | 3 | 163 | 3 | 12906867 | ||
| Pubmed | Human CLEC18 Gene Cluster Contains C-type Lectins with Differential Glycan-binding Specificity. | 1.01e-07 | 3 | 163 | 3 | 26170455 | |
| Pubmed | 1.01e-07 | 3 | 163 | 3 | 20143645 | ||
| Pubmed | 1.01e-07 | 3 | 163 | 3 | 3782802 | ||
| Pubmed | 1.01e-07 | 3 | 163 | 3 | 20702729 | ||
| Pubmed | 2.07e-07 | 54 | 163 | 6 | 8482578 | ||
| Pubmed | Risk of non-Hodgkin lymphoma in association with germline variation in complement genes. | 3.27e-07 | 31 | 163 | 5 | 19344414 | |
| Pubmed | 4.03e-07 | 4 | 163 | 3 | 27165610 | ||
| Pubmed | 4.03e-07 | 4 | 163 | 3 | 6967858 | ||
| Pubmed | Genomic organization of the human kallikrein gene family on chromosome 19q13.3-q13.4. | 4.03e-07 | 4 | 163 | 3 | 11006094 | |
| Pubmed | 4.03e-07 | 4 | 163 | 3 | 24983375 | ||
| Pubmed | 4.03e-07 | 4 | 163 | 3 | 6973596 | ||
| Pubmed | 4.03e-07 | 4 | 163 | 3 | 16709836 | ||
| Pubmed | 4.03e-07 | 4 | 163 | 3 | 37499656 | ||
| Pubmed | 4.49e-07 | 14 | 163 | 4 | 23577725 | ||
| Pubmed | 4.49e-07 | 14 | 163 | 4 | 11054574 | ||
| Pubmed | 6.81e-07 | 153 | 163 | 8 | 25037231 | ||
| Pubmed | C3-dependent mechanism of microglial priming relevant to multiple sclerosis. | 1.00e-06 | 5 | 163 | 3 | 22219359 | |
| Pubmed | Complement-dependent P-selectin expression and injury following ischemic stroke. | 1.00e-06 | 5 | 163 | 3 | 17082645 | |
| Pubmed | 1.00e-06 | 5 | 163 | 3 | 20675597 | ||
| Pubmed | 1.00e-06 | 5 | 163 | 3 | 9799332 | ||
| Pubmed | Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo. | 1.71e-06 | 19 | 163 | 4 | 22561518 | |
| Pubmed | 2.00e-06 | 6 | 163 | 3 | 27196323 | ||
| Pubmed | 2.00e-06 | 6 | 163 | 3 | 38701199 | ||
| Pubmed | 2.00e-06 | 6 | 163 | 3 | 23235567 | ||
| Pubmed | Dimerization of complement factor H-related proteins modulates complement activation in vivo. | 2.00e-06 | 6 | 163 | 3 | 23487775 | |
| Pubmed | 2.00e-06 | 6 | 163 | 3 | 18541031 | ||
| Pubmed | 2.00e-06 | 6 | 163 | 3 | 17438673 | ||
| Pubmed | Murine systemic thrombophilia and hemolytic uremic syndrome from a factor H point mutation. | 3.49e-06 | 7 | 163 | 3 | 28057640 | |
| Pubmed | 3.49e-06 | 7 | 163 | 3 | 19861685 | ||
| Pubmed | Transmembrane homodimerization of receptor-like protein tyrosine phosphatases. | 3.49e-06 | 7 | 163 | 3 | 15978577 | |
| Pubmed | 3.49e-06 | 7 | 163 | 3 | 10969073 | ||
| Pubmed | 3.49e-06 | 7 | 163 | 3 | 20513133 | ||
| Pubmed | 3.49e-06 | 7 | 163 | 3 | 10693874 | ||
| Pubmed | The regulation of the complement system: insights from genetically-engineered mice. | 3.49e-06 | 7 | 163 | 3 | 12914820 | |
| Pubmed | 4.59e-06 | 24 | 163 | 4 | 15331780 | ||
| Pubmed | Serum lipid biomarkers and hepatic lipase gene associations with age-related macular degeneration. | 5.56e-06 | 8 | 163 | 3 | 20888482 | |
| Pubmed | 5.56e-06 | 8 | 163 | 3 | 20301598 | ||
| Pubmed | Mouse kalinin B1 (laminin beta 3 chain): cloning and tissue distribution. | 5.56e-06 | 8 | 163 | 3 | 7898049 | |
| Pubmed | Linkage of genes for laminin B1 and B2 subunits on chromosome 1 in mouse. | 5.56e-06 | 8 | 163 | 3 | 2993224 | |
| Pubmed | Upg-2: a urinary pepsinogen variant located on chromosome 1 of the mouse. | 5.56e-06 | 8 | 163 | 3 | 7165695 | |
| Pubmed | Chromosome mapping of Rmp-4, a gonad-dependent gene encoding host resistance to mousepox. | 5.56e-06 | 8 | 163 | 3 | 7474114 | |
| Pubmed | 5.56e-06 | 8 | 163 | 3 | 38820498 | ||
| Pubmed | 7.50e-06 | 27 | 163 | 4 | 2574151 | ||
| Pubmed | FHR-1 Binds to C-Reactive Protein and Enhances Rather than Inhibits Complement Activation. | 8.32e-06 | 9 | 163 | 3 | 28533443 | |
| Pubmed | 8.32e-06 | 9 | 163 | 3 | 18947875 | ||
| Pubmed | 1.18e-05 | 10 | 163 | 3 | 3384439 | ||
| Pubmed | Circulating AIM prevents hepatocellular carcinoma through complement activation. | 1.18e-05 | 10 | 163 | 3 | 25284781 | |
| Pubmed | 1.18e-05 | 10 | 163 | 3 | 3416634 | ||
| Pubmed | 1.18e-05 | 10 | 163 | 3 | 22705344 | ||
| Pubmed | 1.62e-05 | 11 | 163 | 3 | 20301541 | ||
| Pubmed | Combination of factor H mutation and properdin deficiency causes severe C3 glomerulonephritis. | 1.62e-05 | 11 | 163 | 3 | 23204401 | |
| Pubmed | Zinc transporter Slc39a8 is essential for cardiac ventricular compaction. | 1.62e-05 | 11 | 163 | 3 | 29337306 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 15385269 | ||
| Pubmed | Absence of complement factor H reduces physical performance in C57BL6 mice. | 2.18e-05 | 2 | 163 | 2 | 32962822 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 14635039 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 22677127 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 31984663 | ||
| Pubmed | Transgenic mice expressing variants of complement factor H develop AMD-like retinal findings. | 2.18e-05 | 2 | 163 | 2 | 20538999 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 30068374 | ||
| Pubmed | Inheritance, hormonal regulation and properties of polymorphic murine antigens Mud1 and Mud2. | 2.18e-05 | 2 | 163 | 2 | 4992636 | |
| Pubmed | Retinal changes precede visual dysfunction in the complement factor H knockout mouse. | 2.18e-05 | 2 | 163 | 2 | 23844226 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 16299065 | ||
| Pubmed | E-selectin and P-selectin expression in endothelium of leprosy skin lesions. | 2.18e-05 | 2 | 163 | 2 | 26051909 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 26374608 | ||
| Pubmed | A gene locus concerned with an antigenic serum substance in Mus musculus. | 2.18e-05 | 2 | 163 | 2 | 4955525 | |
| Pubmed | Complement factor H: spatial and temporal expression and localization in the eye. | 2.18e-05 | 2 | 163 | 2 | 16936129 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 12881311 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 20010946 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 33558624 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 37940659 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 24498435 | ||
| Pubmed | E- and P-selectins synergistically inhibit bleomycin-induced pulmonary fibrosis. | 2.18e-05 | 2 | 163 | 2 | 16936251 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 30705315 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 33859044 | ||
| Pubmed | Regulation of age-related macular degeneration-like pathology by complement factor H. | 2.18e-05 | 2 | 163 | 2 | 25991857 | |
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 8874194 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 8620001 | ||
| Pubmed | 2.18e-05 | 2 | 163 | 2 | 25000467 | ||
| Interaction | C3 interactions | 3.22e-06 | 155 | 155 | 9 | int:C3 | |
| Cytoband | 1q32 | 2.86e-05 | 49 | 163 | 4 | 1q32 | |
| Cytoband | 1q22-q25 | 3.75e-05 | 3 | 163 | 2 | 1q22-q25 | |
| Cytoband | 15q25.2 | 4.89e-04 | 43 | 163 | 3 | 15q25.2 | |
| Cytoband | 3q13 | 6.75e-04 | 11 | 163 | 2 | 3q13 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | SELE SELP CFH CFHR5 CSMD2 CR1 CR2 CSMD3 SEZ6L2 SVEP1 CFHR4 SRPX2 C2 SRPX CSMD1 | 2.53e-20 | 57 | 124 | 15 | 1179 |
| GeneFamily | Complement system|Sushi domain containing | 1.00e-10 | 36 | 124 | 8 | 492 | |
| GeneFamily | Kallikreins | 5.75e-08 | 16 | 124 | 5 | 616 | |
| GeneFamily | Immunoglobulin like domain containing | BOC NPHS1 TARM1 DSCAM ADAMTSL3 ADGRA2 TYRO3 FCGR2A PTPRM SIGIRR | 8.65e-07 | 193 | 124 | 10 | 594 |
| GeneFamily | Fibronectin type III domain containing | 1.46e-05 | 160 | 124 | 8 | 555 | |
| GeneFamily | CD molecules|Selectins|Sushi domain containing|C-type lectin domain containing | 1.39e-04 | 3 | 124 | 2 | 945 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 2.82e-04 | 19 | 124 | 3 | 50 | |
| GeneFamily | C-type lectin domain family | 2.99e-04 | 47 | 124 | 4 | 494 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 3.83e-04 | 21 | 124 | 3 | 813 | |
| GeneFamily | Laminin subunits | 2.94e-03 | 12 | 124 | 2 | 626 | |
| GeneFamily | Tubulin tyrosine ligase family | 4.02e-03 | 14 | 124 | 2 | 779 | |
| GeneFamily | Ring finger proteins|Tripartite motif containing|ARF GTPase family | 4.15e-03 | 95 | 124 | 4 | 59 | |
| GeneFamily | CD molecules|I-set domain containing|Immunoglobulin like domain containing|Interleukin receptors|TIR domain containing | 4.62e-03 | 15 | 124 | 2 | 1296 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 5.06e-03 | 161 | 124 | 5 | 593 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 5.82e-03 | 394 | 124 | 8 | 471 | |
| Coexpression | LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2 | PCSK5 ANK2 ANK3 ZC3H13 TNRC6B CUBN PTPRG PTPRJ PTPRM SETBP1 PLG GOLGB1 | 1.52e-08 | 221 | 163 | 12 | M39222 |
| Coexpression | NABA_MATRISOME | PCSK5 FLG CLEC18A CLEC18B LAMA1 CLEC18C LAMB1 HTRA4 TECTA FREM3 ADAMTSL3 F12 SVEP1 MST1 COL18A1 COL24A1 SRPX2 EGF ADAMTS7 ADAMTS16 ADAMTS15 SRPX SEMA4A PLG | 2.42e-08 | 1026 | 163 | 24 | M5889 |
| Coexpression | NABA_MATRISOME | PCSK5 CLEC18A CLEC18B LAMA1 CLEC18C LAMB1 HTRA4 TECTA FREM3 ADAMTSL3 F12 SVEP1 MST1 COL18A1 COL24A1 SRPX2 EGF ADAMTS7 ADAMTS16 ADAMTS15 SRPX SEMA4A PLG | 7.64e-08 | 1008 | 163 | 23 | MM17056 |
| Coexpression | GAO_SMALL_INTESTINE_24W_C7_SECRETORY_PROGENITOR | 1.79e-05 | 52 | 163 | 5 | M39150 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | PCSK5 FLG CLEC18A CLEC18B CLEC18C HTRA4 FREM3 ADAMTSL3 F12 MST1 EGF ADAMTS7 ADAMTS16 ADAMTS15 SEMA4A PLG | 1.96e-05 | 751 | 163 | 16 | M5885 |
| Coexpression | HAY_BONE_MARROW_STROMAL | CFH BOC ANK2 MCC CFI ADAMTSL3 LDLR SVEP1 SRPX2 TENM4 PTPRG NRXN2 PTPRM MRC2 TNKS1BP1 SRPX | 2.52e-05 | 767 | 163 | 16 | M39209 |
| Coexpression | HALLMARK_COAGULATION | 2.59e-05 | 138 | 163 | 7 | M5946 | |
| Coexpression | DESCARTES_ORGANOGENESIS_HEPATOCYTES | MGAM TICAM1 CUBN CFI LDLR RNF43 F12 CFHR4 MST1 SIGIRR C2 SEMA4A PLG | 3.21e-05 | 535 | 163 | 13 | MM3635 |
| Coexpression | HOLLERN_EMT_BREAST_TUMOR_UP | 3.72e-05 | 146 | 163 | 7 | MM964 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | PCSK5 CLEC18A CLEC18B CLEC18C HTRA4 FREM3 ADAMTSL3 F12 MST1 EGF ADAMTS7 ADAMTS16 ADAMTS15 SEMA4A PLG | 6.12e-05 | 738 | 163 | 15 | MM17058 |
| Coexpression | LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM | PCSK5 ZC3H13 TNRC6B CUBN CSMD2 TENM4 NSMF PTPRG PLG CSMD1 GOLGB1 | 6.39e-05 | 417 | 163 | 11 | M39224 |
| ToppCell | Control-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | SELP CFH PCSK5 THSD7A MCC SRPX2 PTPRG PTPRJ MRC2 SETBP1 SRPX CSMD1 | 7.14e-12 | 192 | 163 | 12 | 7e89b9125e8b85f6be85eeccef5c8644647ab0e1 |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | CFH PCSK5 LAMB1 ADAMTSL3 SVEP1 COL18A1 SRPX2 TENM4 MRC2 SETBP1 SRPX | 1.40e-10 | 192 | 163 | 11 | 60b1312e84f6d6448365a952469c506c00b5fe93 |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | CFH BOC ZNF536 LAMB1 ADAMTSL3 SVEP1 COL24A1 TENM4 PTPRG SETBP1 | 1.92e-09 | 187 | 163 | 10 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.87e-08 | 185 | 163 | 9 | 9faa35ceb89ccd2979072286f063687c9f846ce3 | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.29e-08 | 188 | 163 | 9 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | COPD-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 3.78e-08 | 191 | 163 | 9 | ef16ad1c1cd2c0c0377957398c98775b62a81754 | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 3.95e-08 | 192 | 163 | 9 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.95e-08 | 192 | 163 | 9 | e0f4e4470a71bfa81d9dcd8594e5f82aafc24f81 | |
| ToppCell | Mesenchymal-matrix_fibroblast_2_cell|World / Lineage, Cell type, age group and donor | 3.95e-08 | 192 | 163 | 9 | a769158c49d2b208c4224d85e7ae68c85cc372ed | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 4.13e-08 | 193 | 163 | 9 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-10|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 4.13e-08 | 193 | 163 | 9 | 194e7fa00a50cc4e026987b715323d125d79594e | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 4.51e-08 | 195 | 163 | 9 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 4.93e-08 | 197 | 163 | 9 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | tumor_Lung-Fibroblasts-COL14A1+_matrix_FBs|tumor_Lung / Location, Cell class and cell subclass | 5.14e-08 | 198 | 163 | 9 | 74f2c7ef702b25a5b99e56121229e678ed992524 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.14e-08 | 198 | 163 | 9 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 5.37e-08 | 199 | 163 | 9 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.61e-08 | 200 | 163 | 9 | ad3fdcef895400f929f2ae12ff9bd85fd46adb3a | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.61e-08 | 200 | 163 | 9 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_1-AF2|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.61e-08 | 200 | 163 | 9 | 44317fbf4d1480a37b50ab2777bf1a3e4fc0c05f | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.61e-08 | 200 | 163 | 9 | 54806080b5e97859ee6a4a9b4f19e22021c218f5 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.61e-08 | 200 | 163 | 9 | 74e74123ea7bf38d337a3a0248a6a51437c6ab42 | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.61e-08 | 200 | 163 | 9 | 1c10597edd532bf172ca09870a937d35e2585081 | |
| ToppCell | cellseq2-Mesenchymal-Fibroblastic-Fibroblastic_1|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.61e-08 | 200 | 163 | 9 | 440dda48b09c6a8581b7ca634b0d67f1ecacf65e | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-07 | 176 | 163 | 8 | fee4e0f32aaf77294040c7af6c1f503571750d43 | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-07 | 176 | 163 | 8 | f25251abd4ef9fb077a978f9f9f658af58e4e0d2 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.03e-07 | 177 | 163 | 8 | bd602db857f37869ef76d14c05ef522c509f08ee | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.44e-07 | 180 | 163 | 8 | e8841ef1239f9ee73ac4f4e11faca0742694f368 | |
| ToppCell | 5'-Adult-LymphNode-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.59e-07 | 181 | 163 | 8 | ab66a89f316b935d9ba1277426d976b1e9e39757 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.74e-07 | 182 | 163 | 8 | 3dfa9187e9d2bab1d199079d29209c4648220ada | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-kidney_collecting_duct_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.74e-07 | 182 | 163 | 8 | ccfee33de0faebbe69099d4ff3c3971f6a708b99 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.90e-07 | 183 | 163 | 8 | 8330c39184ce076e1f95fd3725b68af551d89db0 | |
| ToppCell | wk_20-22-Mesenchymal-Mesothelial|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.06e-07 | 184 | 163 | 8 | 804f8a41cd6b1361448872bf352bf0a38a0fac66 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D122|Adult / Lineage, Cell type, age group and donor | 4.06e-07 | 184 | 163 | 8 | 2b7e6f91e11c228f0521e099886867d9e998e78d | |
| ToppCell | wk_20-22-Mesenchymal-Mesothelial-Late_mesothelial|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 4.06e-07 | 184 | 163 | 8 | 60dd055c2e2e92b838ac649c12e8cccd9c3b1b71 | |
| ToppCell | COVID-19-Fibroblasts-Adventitial_FB|COVID-19 / group, cell type (main and fine annotations) | 4.23e-07 | 185 | 163 | 8 | a5aebf2b9b05b550d021272731d68af9a6b1229d | |
| ToppCell | Control-Endothelial_cells-Arterial_endothelial_cells|Control / group, cell type (main and fine annotations) | 4.59e-07 | 187 | 163 | 8 | 81affaab3fe3e1daea45ada6445e906ddd33950e | |
| ToppCell | 5'-Airway_Nasal-Endothelial-Blood_vessel_EC-vein_endothelial_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.78e-07 | 188 | 163 | 8 | 524d1d928c9386acf20e53d31894107dd7290dc7 | |
| ToppCell | 5'-Airway_Nasal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic-EC_venous_systemic_L.2.2.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.78e-07 | 188 | 163 | 8 | 1b57995d70cf81212e8d46dfaf44dbaf9c7bc4d5 | |
| ToppCell | 5'-Airway_Nasal-Endothelial-Blood_vessel_EC|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.78e-07 | 188 | 163 | 8 | cd2d1f8e43c252dd8730a5758458ef63e7ffc836 | |
| ToppCell | Control-Fibroblasts-Adventitial_FB|Control / group, cell type (main and fine annotations) | 4.78e-07 | 188 | 163 | 8 | 706a26c372add839d947749f0521a0e1f5c9b0ec | |
| ToppCell | 5'-Airway_Nasal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.78e-07 | 188 | 163 | 8 | f5a2f324f3f6c5078d57130392d3f1ba74f29094 | |
| ToppCell | 5'-Airway_Nasal-Endothelial|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.78e-07 | 188 | 163 | 8 | 6c9d5e4014f807149328ff4eabd5e86dfe18094d | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 4.98e-07 | 189 | 163 | 8 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D175|Adult / Lineage, Cell type, age group and donor | 5.18e-07 | 190 | 163 | 8 | 7dcca3469f3a3b70db0420cb94f7765f39492f06 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.18e-07 | 190 | 163 | 8 | f6c38d197fd9d69a4f97cb2e72cd4747984c1a86 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-AEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 5.39e-07 | 191 | 163 | 8 | 50601ef0a5a8f2c2120922989e08e85bf2d9b4ab | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.61e-07 | 192 | 163 | 8 | 8d56e360ebc624ca4cd7f0af4f3cc599c244f134 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.61e-07 | 192 | 163 | 8 | c3707243c5590d852c9f28429c96f50a1fa6b0dc | |
| ToppCell | IPF-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 5.61e-07 | 192 | 163 | 8 | e911e286da26202853f9650ba3cdefe5a5c9b585 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.61e-07 | 192 | 163 | 8 | 8937a59f6bbe07f671bdabbd3707dc9c17a14cd9 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.61e-07 | 192 | 163 | 8 | e4a7f2673f801b008ca67291db2fb2b9fd2955b8 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.61e-07 | 192 | 163 | 8 | ac1477433704573f95111eee6263b93668d2845e | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.61e-07 | 192 | 163 | 8 | 136af0186c70c14c5f2b33ed7a148156de5b478c | |
| ToppCell | Fibroblasts-CD55+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 5.84e-07 | 193 | 163 | 8 | 8f4bf9a2fbedae35432dad96730b00c70185874c | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.84e-07 | 193 | 163 | 8 | ec81c1afdae2e0433a22c8c1fa1c6232526ff7e7 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.84e-07 | 193 | 163 | 8 | 30481fb01c7acf85beae10213f038da86bed6777 | |
| ToppCell | 3'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.07e-07 | 194 | 163 | 8 | e2db75f4de114631b8bda4e188f84446545538b7 | |
| ToppCell | RV-02._Fibroblast_II|RV / Chamber and Cluster_Paper | 6.07e-07 | 194 | 163 | 8 | 11c79a8c56ece42713b04b321982e41e239f07a5 | |
| ToppCell | LV-02._Fibroblast_II|LV / Chamber and Cluster_Paper | 6.07e-07 | 194 | 163 | 8 | 014d2feb5db2a6a35ef759761a41e466e108c3c1 | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.31e-07 | 195 | 163 | 8 | 023e3c97dd3696d74f002ff8da0c04d876c82aef | |
| ToppCell | RA-02._Fibroblast_II|RA / Chamber and Cluster_Paper | 6.31e-07 | 195 | 163 | 8 | 6a02ebbeb3199447ddce64d92d8809436e040eba | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.31e-07 | 195 | 163 | 8 | f5e91ce20a7ce528dc4c1a968c7bf096bf45c528 | |
| ToppCell | facs-Thymus-Thymus_Epithelium|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.56e-07 | 196 | 163 | 8 | 6bc1187dfc4860a4e09032d7ea87ba3d9fe9f363 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.56e-07 | 196 | 163 | 8 | 525d6c8a277364e624e7cc586275f8a891436b57 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.56e-07 | 196 | 163 | 8 | c8c89e469402e11aa2a9561e859b6fd1fb66c39b | |
| ToppCell | (5)_Fibroblast-J_(Lipofibroblast)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 6.56e-07 | 196 | 163 | 8 | afa29399decd17fda7d63add5039ff778627ccc2 | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.56e-07 | 196 | 163 | 8 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | RA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 6.56e-07 | 196 | 163 | 8 | e8cbda03837f1f26470a9d93aa7fdaa04e08e38a | |
| ToppCell | distal-mesenchymal-Lipofibroblast-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.81e-07 | 197 | 163 | 8 | 865010edcd7e3f79f505fcef7b33882095994aa8 | |
| ToppCell | distal-mesenchymal-Lipofibroblast|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.81e-07 | 197 | 163 | 8 | ceb83bdef16b58ee16193413bfb006f7715728b2 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.81e-07 | 197 | 163 | 8 | 2744cc94883c5d0424677cf5093bbab622933e9b | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.81e-07 | 197 | 163 | 8 | 44673c38384453207871d3fd8e8ba9093cc06bc5 | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 7.08e-07 | 198 | 163 | 8 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | Fibroblasts-HLA-DRA_high_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 7.08e-07 | 198 | 163 | 8 | e8c0fbf306fae13e97caa294d7c99a564bd97130 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_immune_recruiting|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.35e-07 | 199 | 163 | 8 | 0cdbedf09ec72734b86ddab3fec562e066afed92 | |
| ToppCell | Fibroblasts-CD34+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 7.35e-07 | 199 | 163 | 8 | 13ff7409e200a0b46cdb7924d15ef33639693622 | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.35e-07 | 199 | 163 | 8 | 21335475bbfbad8a6943b8076a6c1c67f3eec5d3 | |
| ToppCell | Biopsy_IPF-Mesenchymal-PLIN2+_Fibroblasts|Biopsy_IPF / Sample group, Lineage and Cell type | 7.64e-07 | 200 | 163 | 8 | 2c5626ea8fb4b702d4560117e53edf6cfcf1971e | |
| ToppCell | Bronchial-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.64e-07 | 200 | 163 | 8 | 5ea12e17f50fefbf5534e487af3392b2fa2d13ad | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.64e-07 | 200 | 163 | 8 | 6f7f015b5fa1f52374f2c7d9ba339012395eda5f | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Mesenchymal-Mesothelium|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 7.64e-07 | 200 | 163 | 8 | c082bc21ec7c5323439d108ea8aea510e1113c3f | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.64e-07 | 200 | 163 | 8 | b4ccffdd79526c85e5273d27b668dbddcddba1ee | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.64e-07 | 200 | 163 | 8 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.64e-07 | 200 | 163 | 8 | 3a164e3971bcd62b148b813171c103adb81f972e | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_adventitial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.64e-07 | 200 | 163 | 8 | b04831708fa20471a127b87e8db3728b6e729ce8 | |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.64e-07 | 200 | 163 | 8 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 7.64e-07 | 200 | 163 | 8 | 6316c288022719b9e6c4332c5cb9041e1188d0e8 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.64e-07 | 200 | 163 | 8 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_adventitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.64e-07 | 200 | 163 | 8 | 0c25d56292b9e5fefa4521b72635449be1ffd6fe | |
| ToppCell | healthy_donor-Lymphocytic-T_cell-CD4+_T_cell_(ISG_high)|healthy_donor / Disease condition, Lineage, Cell class and subclass | 7.83e-07 | 138 | 163 | 7 | 97f5dc17522462133e582b508ad0ef036e656872 | |
| ToppCell | 367C-Myeloid-Macrophage-SPP1+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.78e-06 | 156 | 163 | 7 | fc8b8aef29d6d1c0f0c1d08280d8aaff8d30535e | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.86e-06 | 157 | 163 | 7 | f147e24f2ece82e1c54750868954d09b3c461804 | |
| ToppCell | TCGA-Skin-Primary_Tumor-Melanoma-Skin_Cutaneous_Melanoma-3|TCGA-Skin / Sample_Type by Project: Shred V9 | 2.08e-06 | 102 | 163 | 6 | 57a30ef6ac6ee623bb328b945a9d7c9a56d40a4e | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-Mature_Fibroblast_1|E16.5-samps / Age Group, Lineage, Cell class and subclass | 2.39e-06 | 163 | 163 | 7 | f1ec2625b52664308968b01d8e0275e1e0751480 | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.03e-06 | 169 | 163 | 7 | 849a8f8509c58d65462a09c84d58b6ecdc8934f5 | |
| ToppCell | RA-01._Fibroblast_I|RA / Chamber and Cluster_Paper | 3.03e-06 | 169 | 163 | 7 | 6373562ab3b1765060212a6a53d6543e7e942e80 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.82e-06 | 175 | 163 | 7 | e5467dacf81f1f913b1719931cf1a7331434a7e7 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.96e-06 | 176 | 163 | 7 | 1595dbeee336a81e581325d63208ec6262664ee9 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 4.11e-06 | 177 | 163 | 7 | 3d955ea938a1d2fb1b6d68d4997fd454bd632dfc | |
| ToppCell | ASK428-Epithelial-Secretory|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.11e-06 | 177 | 163 | 7 | 66074a288501c136b4e83b883db5f0d8269ee326 | |
| Computational | Serine proteases. | 9.24e-07 | 39 | 93 | 6 | MODULE_109 | |
| Computational | Genes in the cancer module 58. | 2.81e-05 | 21 | 93 | 4 | MODULE_58 | |
| Computational | Complement. | 4.10e-05 | 23 | 93 | 4 | MODULE_130 | |
| Computational | Neighborhood of IGFBP1 | 1.28e-04 | 57 | 93 | 5 | CAR_IGFBP1 | |
| Computational | Genes in the cancer module 27. | 2.36e-04 | 355 | 93 | 11 | MODULE_27 | |
| Computational | Neighborhood of HPX | 4.11e-04 | 73 | 93 | 5 | CAR_HPX | |
| Computational | Genes in the cancer module 107. | 5.92e-04 | 79 | 93 | 5 | MODULE_107 | |
| Computational | Catabolic peptidases. | 1.02e-03 | 89 | 93 | 5 | MODULE_209 | |
| Drug | Leupeptin hydrochloride | BOC MGAM KLK14 KLK12 CUBN F12 TG SPTBN5 EGF MRC2 KLK8 PLG KLK13 KLK1 | 9.33e-09 | 276 | 159 | 14 | CID000003910 |
| Drug | L-lysyl-L-lysyl-L-lysine | SELE SELP KLK14 KLK12 TG COL18A1 COL24A1 EGF KLK8 KLK13 KLK1 | 1.96e-08 | 162 | 159 | 11 | CID000072363 |
| Drug | DB04780 | SELE SELP KLK14 LAMB1 KLK12 F12 ADAMTS7 KLK8 ADAMTS15 KLK13 KLK1 | 3.23e-08 | 170 | 159 | 11 | CID005459389 |
| Drug | LMWH | SELE SELP CFH BOC LAMA1 KLK14 LAMB1 KLK12 CFHR5 LDLR F12 CFHR4 COL18A1 COL24A1 EGF FCGR2A KLK8 PLG KLK13 KLK1 | 4.15e-08 | 663 | 159 | 20 | CID000000772 |
| Drug | desogestrel | 5.80e-08 | 106 | 159 | 9 | CID000040973 | |
| Drug | chlorazanil | 6.40e-08 | 16 | 159 | 5 | CID000010374 | |
| Drug | FFRck | 1.21e-07 | 34 | 159 | 6 | CID000126484 | |
| Drug | beta-estradiol 3-benzoate | 2.95e-07 | 128 | 159 | 9 | CID000003262 | |
| Drug | S2266 | 3.33e-07 | 40 | 159 | 6 | CID000122333 | |
| Drug | B3852 | 3.73e-07 | 22 | 159 | 5 | CID003081658 | |
| Drug | Etiocobalamin | 4.91e-07 | 177 | 159 | 10 | CID006450878 | |
| Drug | AC1Q6PCP | PPRC1 KLK14 KLK12 COL18A1 COL24A1 TONSL KLK8 AHR CACNA1I KLK13 KLK1 | 6.86e-07 | 230 | 159 | 11 | CID000005267 |
| Drug | epanolol | 7.40e-07 | 25 | 159 | 5 | CID000072014 | |
| Drug | 4-aminophenyl-beta-D-galactopyranoside | 1.33e-06 | 4 | 159 | 3 | CID000001685 | |
| Drug | MCDF | 1.35e-06 | 28 | 159 | 5 | CID000114900 | |
| Drug | SA446 | 2.29e-06 | 31 | 159 | 5 | CID000071244 | |
| Drug | camostate | 2.80e-06 | 88 | 159 | 7 | CID000002536 | |
| Drug | CAS 76095-16-4 | 2.96e-06 | 126 | 159 | 8 | CID000003222 | |
| Drug | PCB 167 | 3.31e-06 | 5 | 159 | 3 | CID000040479 | |
| Drug | Factor Xiiib | 4.27e-06 | 35 | 159 | 5 | CID000126166 | |
| Drug | AC1L9IGO | 6.07e-06 | 184 | 159 | 9 | CID000445722 | |
| Drug | CHCl | 6.20e-06 | 65 | 159 | 6 | CID006432229 | |
| Drug | Sri 8835 | 6.58e-06 | 6 | 159 | 3 | CID000479975 | |
| Drug | acetone | 6.92e-06 | 187 | 159 | 9 | CID000000180 | |
| Drug | alpha-estradiol; Down 200; 0.01uM; MCF7; HT_HG-U133A_EA | 8.93e-06 | 193 | 159 | 9 | 1048_DN | |
| Drug | benzamidine | 9.29e-06 | 147 | 159 | 8 | CID000002332 | |
| Drug | histamine | SELE SELP BOC KLK14 KLK12 CR2 ITGAX F12 ITPKB FCGR2A TONSL KLK8 AHR KLK13 KLK1 | 9.49e-06 | 560 | 159 | 15 | CID000000774 |
| Drug | T-kinin | 9.54e-06 | 41 | 159 | 5 | CID000123643 | |
| Drug | EACA | 1.13e-05 | 151 | 159 | 8 | CID000000564 | |
| Drug | NSC9700 | SELE NCOA2 BOC TRIM25 KLK14 KLK12 CRHR2 AHRR EGF KLK8 AHR C2 ATM KLK13 KLK1 | 1.38e-05 | 578 | 159 | 15 | CID000005408 |
| Drug | mesterolone | 1.82e-05 | 8 | 159 | 3 | CID000015020 | |
| Drug | 3-CB | 1.82e-05 | 8 | 159 | 3 | CID005326876 | |
| Drug | furosemide | 2.25e-05 | 272 | 159 | 10 | CID000003440 | |
| Drug | S-2390 | 2.72e-05 | 9 | 159 | 3 | CID000192089 | |
| Drug | NSC98537 | NCOA2 TRIM25 BACH2 KLK14 KLK12 EGF SETBP1 NFX1 KLK8 AHR ATM KLK13 KLK1 | 2.93e-05 | 473 | 159 | 13 | CID000005410 |
| Drug | amlodipine | 2.99e-05 | 126 | 159 | 7 | CID000002162 | |
| Drug | sodium chloride | SELE SELP BOC MGAM KLK14 KLK12 B3GNT7 ITGAX TG COL18A1 LLGL1 EGF PTPRM MRC2 KLK8 PRKCSH KLK13 KLK1 | 3.62e-05 | 865 | 159 | 18 | CID000000206 |
| Drug | LTC4 (leukotriene C4 | 4.01e-05 | 180 | 159 | 8 | CID000003907 | |
| Drug | cyclophorine | SELE CFH BOC KLK14 KLK12 CR2 LDLR CFHR4 KLK8 CACNA1I KLK13 KLK1 | 4.73e-05 | 426 | 159 | 12 | CID000002909 |
| Drug | DS50 | 4.85e-05 | 2 | 159 | 2 | CID000205381 | |
| Drug | 6-chloro-2-benzoxazolone | 4.85e-05 | 2 | 159 | 2 | CID000029858 | |
| Drug | 12-tungstophosphate | 4.85e-05 | 2 | 159 | 2 | CID006398471 | |
| Drug | allylthiocyanate | 4.85e-05 | 2 | 159 | 2 | CID000069816 | |
| Drug | benzacridine | 4.85e-05 | 2 | 159 | 2 | CID000009180 | |
| Drug | Mephe-pro-arg | 5.29e-05 | 11 | 159 | 3 | CID000133064 | |
| Drug | Narea | 5.29e-05 | 11 | 159 | 3 | CID000016556 | |
| Drug | N-benzoyl-L-arginine | 5.30e-05 | 58 | 159 | 5 | CID000097369 | |
| Drug | thryroxine | 5.44e-05 | 302 | 159 | 10 | CID000000853 | |
| Drug | Heparin | 5.86e-05 | 140 | 159 | 7 | ctd:D006493 | |
| Drug | Carbamazepine [298-46-4]; Down 200; 17uM; HL60; HT_HG-U133A | 6.33e-05 | 192 | 159 | 8 | 1847_DN | |
| Drug | isocycloheximide | SELE SELP CFH TRIM25 LAMA1 SNAP23 LAMB1 ITGAX LDLR TG AHRR EGF SIGIRR TONSL NFX1 AHR C2 PLG | 6.47e-05 | 905 | 159 | 18 | CID000002900 |
| Drug | MEK1/2 inhibitor | 6.56e-05 | 193 | 159 | 8 | CID009549284 | |
| Drug | Chromozym Pk | 7.02e-05 | 12 | 159 | 3 | CID003080855 | |
| Drug | Isocarboxazid [59-63-2]; Up 200; 17.2uM; HL60; HT_HG-U133A | 7.31e-05 | 196 | 159 | 8 | 2562_UP | |
| Drug | Protoveratrine A [143-57-7]; Down 200; 5uM; MCF7; HT_HG-U133A | 7.58e-05 | 197 | 159 | 8 | 4963_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 7.85e-05 | 198 | 159 | 8 | 3332_DN | |
| Drug | Ethisterone [434-03-7]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 7.85e-05 | 198 | 159 | 8 | 3975_UP | |
| Drug | Cholecalciferol [67-97-0]; Up 200; 10.4uM; HL60; HT_HG-U133A | 7.85e-05 | 198 | 159 | 8 | 2436_UP | |
| Drug | Ajmalicine hydrochloride [4373-34-6]; Up 200; 10.2uM; HL60; HG-U133A | 7.85e-05 | 198 | 159 | 8 | 1748_UP | |
| Drug | Quinic acid [86-68-0]; Up 200; 19.6uM; HL60; HT_HG-U133A | 8.13e-05 | 199 | 159 | 8 | 2978_UP | |
| Drug | Benzocaine [94-09-7]; Up 200; 24.2uM; MCF7; HT_HG-U133A | 8.13e-05 | 199 | 159 | 8 | 2822_UP | |
| Drug | potassium titanyl phosphate | 1.15e-04 | 14 | 159 | 3 | CID000159454 | |
| Drug | Hoe 140 | 1.24e-04 | 110 | 159 | 6 | CID000071362 | |
| Drug | TLCK | 1.25e-04 | 158 | 159 | 7 | CID000004427 | |
| Drug | AC1L1KMJ | ANK2 ANK3 LAMA1 LAMB1 ITGAX SPTBN5 COL18A1 COL24A1 EGF FCGR2A SACS SSX2IP | 1.35e-04 | 476 | 159 | 12 | CID000030956 |
| Drug | Boc-phenylalanine | 1.45e-04 | 3 | 159 | 2 | CID000077857 | |
| Drug | annomontine | 1.45e-04 | 3 | 159 | 2 | ctd:C508838 | |
| Drug | Sr(OH)2 | 1.45e-04 | 3 | 159 | 2 | CID000087672 | |
| Drug | 6-chlorochrysene | 1.45e-04 | 3 | 159 | 2 | CID000056969 | |
| Drug | AC1L386F | 1.45e-04 | 3 | 159 | 2 | CID000136290 | |
| Drug | AC1L2XHC | 1.45e-04 | 3 | 159 | 2 | CID000130491 | |
| Drug | NSC295110 | 1.45e-04 | 3 | 159 | 2 | CID005458605 | |
| Drug | THAb | 1.45e-04 | 3 | 159 | 2 | CID000085419 | |
| Drug | Re(CO)5Br | 1.45e-04 | 3 | 159 | 2 | CID000518902 | |
| Drug | Betamethasone-d5 | SELE NCOA2 CFH BOC PPRC1 LAMA1 KLK14 LAMB1 KLK12 ITGAX LDLR CRHR2 CFHR4 AHRR EGF SIGIRR SETBP1 TONSL KLK8 AHR KLK13 KLK1 | 1.64e-04 | 1340 | 159 | 22 | CID000003003 |
| Drug | CP094 | 1.64e-04 | 165 | 159 | 7 | CID000086322 | |
| Drug | angiotensin | 1.70e-04 | 282 | 159 | 9 | CID003083715 | |
| Drug | methylamine | 1.73e-04 | 222 | 159 | 8 | CID000006329 | |
| Drug | AC1NBU2S | 1.74e-04 | 117 | 159 | 6 | CID004473765 | |
| Drug | tryptanthrin | 1.75e-04 | 16 | 159 | 3 | CID000073549 | |
| Drug | Cimetidine | 1.93e-04 | 76 | 159 | 5 | ctd:D002927 | |
| Disease | kallikrein-11 measurement | 1.03e-07 | 9 | 160 | 4 | EFO_0010573 | |
| Disease | Complement deficiency disease | 9.24e-07 | 33 | 160 | 5 | C0272242 | |
| Disease | kallikrein-13 measurement | 1.55e-06 | 5 | 160 | 3 | EFO_0020512 | |
| Disease | Malignant neoplasm of breast | NCOA2 BOC RTP1 ANK2 TICAM1 UBR4 CFHR5 CUBN TECTA PCDH20 MST1 LLGL1 EGF SETBP1 AHR ATM HERC2 NOTCH1 GOLGB1 ZNF541 | 1.62e-06 | 1074 | 160 | 20 | C0006142 |
| Disease | glucosidase 2 subunit beta measurement | 3.09e-06 | 6 | 160 | 3 | EFO_0801628 | |
| Disease | creatinine measurement | CFH NPHS1 DSCAM TMC6 TNRC6B FSD2 CUBN LDLR KIAA1614 F12 RFWD3 COL18A1 PTPRJ NRXN2 ADAMTS7 SLC22A1 SETBP1 AHR | 8.27e-06 | 995 | 160 | 18 | EFO_0004518 |
| Disease | tyrosine-protein kinase receptor TYRO3 measurement | 8.59e-06 | 8 | 160 | 3 | EFO_0020829 | |
| Disease | age-related macular degeneration | 9.27e-06 | 89 | 160 | 6 | EFO_0001365 | |
| Disease | Atypical hemolytic-uremic syndrome | 1.28e-05 | 9 | 160 | 3 | cv:C2931788 | |
| Disease | C3 glomerulopathy | 1.28e-05 | 9 | 160 | 3 | C4087273 | |
| Disease | Hemolytic-uremic syndrome | 1.28e-05 | 9 | 160 | 3 | cv:C0019061 | |
| Disease | Age related macular degeneration | 2.04e-05 | 30 | 160 | 4 | C0242383 | |
| Disease | hemopexin measurement | 2.50e-05 | 11 | 160 | 3 | EFO_0008149 | |
| Disease | Lupus Erythematosus | 2.92e-05 | 2 | 160 | 2 | C0409974 | |
| Disease | Lupus Vulgaris | 2.92e-05 | 2 | 160 | 2 | C0024131 | |
| Disease | c3d:C3 ratio | 2.92e-05 | 2 | 160 | 2 | EFO_0008543 | |
| Disease | Megaloblastic Anemia 1 | 2.92e-05 | 2 | 160 | 2 | C4551825 | |
| Disease | Megaloblastic anemia due to inborn errors of metabolism | 2.92e-05 | 2 | 160 | 2 | C1306856 | |
| Disease | coronary aneurysm | 3.82e-05 | 35 | 160 | 4 | EFO_1000881 | |
| Disease | kallikrein-12 measurement | 4.30e-05 | 13 | 160 | 3 | EFO_0008194 | |
| Disease | wet macular degeneration | 5.45e-05 | 14 | 160 | 3 | EFO_0004683 | |
| Disease | WAP four-disulfide core domain protein 5 measurement | 8.73e-05 | 3 | 160 | 2 | EFO_0803264 | |
| Disease | vesicle-associated membrane protein 8 measurement | 8.73e-05 | 3 | 160 | 2 | EFO_0803254 | |
| Disease | Drusen, Radial, Autosomal Dominant | 8.73e-05 | 3 | 160 | 2 | C1852021 | |
| Disease | Malattia Leventinese | 8.73e-05 | 3 | 160 | 2 | C1852020 | |
| Disease | calnexin measurement | 8.73e-05 | 3 | 160 | 2 | EFO_0801444 | |
| Disease | brother of CDO measurement | 8.73e-05 | 3 | 160 | 2 | EFO_0020194 | |
| Disease | DOYNE HONEYCOMB RETINAL DYSTROPHY | 8.73e-05 | 3 | 160 | 2 | C1832174 | |
| Disease | B-cell lymphoma 6 protein measurement | 8.73e-05 | 3 | 160 | 2 | EFO_0021933 | |
| Disease | interleukin-17F measurement | 8.73e-05 | 3 | 160 | 2 | EFO_0021963 | |
| Disease | complement factor H-related protein 4A measurement | 8.73e-05 | 3 | 160 | 2 | EFO_0600057 | |
| Disease | tensin-2 measurement | 8.73e-05 | 3 | 160 | 2 | EFO_0802122 | |
| Disease | histone-lysine N-methyltransferase 2D measurement | 8.73e-05 | 3 | 160 | 2 | EFO_0801683 | |
| Disease | Age-related macular degeneration | 1.20e-04 | 18 | 160 | 3 | cv:C0242383 | |
| Disease | Colorectal Carcinoma | BOC ANK2 ZSCAN5A LAMA1 MCC PHETA1 CUBN ADAMTSL3 CSMD3 RNF43 SACS SETBP1 ADAMTS15 | 1.25e-04 | 702 | 160 | 13 | C0009402 |
| Disease | Hereditary Non-Polyposis Colon Cancer Type 2 | 1.42e-04 | 19 | 160 | 3 | C1333991 | |
| Disease | Colorectal cancer, hereditary nonpolyposis, type 1 | 1.42e-04 | 19 | 160 | 3 | C2936783 | |
| Disease | coagulation factor measurement | 1.67e-04 | 20 | 160 | 3 | EFO_0004634 | |
| Disease | NADH dehydrogenase [ubiquinone] iron-sulfur protein 4, mitochondrial measurement | 1.74e-04 | 4 | 160 | 2 | EFO_0803292 | |
| Disease | cullin-9 measurement | 1.74e-04 | 4 | 160 | 2 | EFO_0802437 | |
| Disease | alanine aminotransferase 1 measurement | 1.74e-04 | 4 | 160 | 2 | EFO_0802260 | |
| Disease | kallikrein-5 measurement | 1.74e-04 | 4 | 160 | 2 | EFO_0020515 | |
| Disease | HELLP Syndrome | 1.74e-04 | 4 | 160 | 2 | C0162739 | |
| Disease | cystatin-8 measurement | 2.89e-04 | 5 | 160 | 2 | EFO_0801509 | |
| Disease | Jaw Abnormalities | 2.89e-04 | 5 | 160 | 2 | C0022360 | |
| Disease | tight junction protein ZO-1 measurement | 2.89e-04 | 5 | 160 | 2 | EFO_0803155 | |
| Disease | Lupus Erythematosus, Discoid | 2.89e-04 | 5 | 160 | 2 | C0024138 | |
| Disease | hephaestin-like protein 1 measurement | 2.89e-04 | 5 | 160 | 2 | EFO_0802597 | |
| Disease | interferon alpha-5 measurement | 2.89e-04 | 5 | 160 | 2 | EFO_0802642 | |
| Disease | ATP-dependent RNA helicase A measurement | 2.89e-04 | 5 | 160 | 2 | EFO_0802294 | |
| Disease | synaptotagmin-like protein 4 measurement | 2.89e-04 | 5 | 160 | 2 | EFO_0802109 | |
| Disease | matrix extracellular phosphoglycoprotein measurement | 2.89e-04 | 5 | 160 | 2 | EFO_0020557 | |
| Disease | atrophic macular degeneration, age-related macular degeneration, wet macular degeneration | 3.21e-04 | 60 | 160 | 4 | EFO_0001365, EFO_0004683, EFO_1001492 | |
| Disease | atrophic macular degeneration | 3.30e-04 | 25 | 160 | 3 | EFO_1001492 | |
| Disease | Hereditary Nonpolyposis Colorectal Neoplasms | 3.71e-04 | 26 | 160 | 3 | C0009405 | |
| Disease | L lactate dehydrogenase measurement | 3.71e-04 | 26 | 160 | 3 | EFO_0004808 | |
| Disease | cortical surface area measurement | TRPM6 NCOA2 ZNF536 ANK3 NBEAL1 ZC3H13 PRSS55 TNRC6B ADAMTSL3 ADGRA2 KIAA1614 SVEP1 TG COL24A1 FAM168A ADAMTS7 ARHGAP12 RHOT1 | 3.84e-04 | 1345 | 160 | 18 | EFO_0010736 |
| Disease | Ulcerative Colitis | 3.87e-04 | 63 | 160 | 4 | C0009324 | |
| Disease | Hereditary non-polyposis colorectal cancer syndrome | 4.16e-04 | 27 | 160 | 3 | C1112155 | |
| Disease | macular degeneration (is_implicated_in) | 4.16e-04 | 27 | 160 | 3 | DOID:4448 (is_implicated_in) | |
| Disease | blood manganese measurement | 4.16e-04 | 27 | 160 | 3 | EFO_0007581 | |
| Disease | CD63 antigen measurement | 4.32e-04 | 6 | 160 | 2 | EFO_0022033 | |
| Disease | galectin-7 measurement | 4.32e-04 | 6 | 160 | 2 | EFO_0022034 | |
| Disease | serine/threonine-protein kinase ULK3 measurement | 4.32e-04 | 6 | 160 | 2 | EFO_0803065 | |
| Disease | foot muscle strength measurement | 4.32e-04 | 6 | 160 | 2 | EFO_0009699 | |
| Disease | progonadoliberin-1 measurement | 4.32e-04 | 6 | 160 | 2 | EFO_0801924 | |
| Disease | complement C1s subcomponent measurement | 4.32e-04 | 6 | 160 | 2 | EFO_0008091 | |
| Disease | interleukin-23 receptor measurement | 4.32e-04 | 6 | 160 | 2 | EFO_0801725 | |
| Disease | Hereditary Nonpolyposis Colorectal Cancer | 5.15e-04 | 29 | 160 | 3 | C1333990 | |
| Disease | urate measurement, bone density | TRPM6 DSCAM BACH2 PRSS55 MCC DNAH14 ITPKB TG PTPRG ADAMTS16 C2 | 5.89e-04 | 619 | 160 | 11 | EFO_0003923, EFO_0004531 |
| Disease | long QT syndrome (is_implicated_in) | 6.03e-04 | 7 | 160 | 2 | DOID:2843 (is_implicated_in) | |
| Disease | cadherin-15 measurement | 6.03e-04 | 7 | 160 | 2 | EFO_0020211 | |
| Disease | baculoviral IAP repeat-containing protein 5 measurement | 6.03e-04 | 7 | 160 | 2 | EFO_0020174 | |
| Disease | functional impairment measurement | 6.03e-04 | 7 | 160 | 2 | EFO_0005412 | |
| Disease | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 measurement | 6.03e-04 | 7 | 160 | 2 | EFO_0020108 | |
| Disease | hereditary angioedema (is_implicated_in) | 6.03e-04 | 7 | 160 | 2 | DOID:14735 (is_implicated_in) | |
| Disease | C-C motif chemokine 1 measurement | 6.03e-04 | 7 | 160 | 2 | EFO_0008041 | |
| Disease | r-spondin-3 measurement | 6.03e-04 | 7 | 160 | 2 | EFO_0021878 | |
| Disease | angina pectoris | 6.12e-04 | 125 | 160 | 5 | EFO_0003913 | |
| Disease | Hypertensive disease | 6.15e-04 | 190 | 160 | 6 | C0020538 | |
| Disease | L-Selectin measurement | 6.29e-04 | 31 | 160 | 3 | EFO_0008202 | |
| Disease | tumor necrosis factor receptor superfamily member 19L measurement | 8.01e-04 | 8 | 160 | 2 | EFO_0008309 | |
| Disease | stabilin-2 measurement | 8.01e-04 | 8 | 160 | 2 | EFO_0020752 | |
| Disease | neurexophilin-1 measurement | 8.01e-04 | 8 | 160 | 2 | EFO_0008244 | |
| Disease | atypical hemolytic-uremic syndrome (is_implicated_in) | 8.01e-04 | 8 | 160 | 2 | DOID:0080301 (is_implicated_in) | |
| Disease | bitter alcoholic beverage consumption measurement | 8.10e-04 | 133 | 160 | 5 | EFO_0010092 | |
| Disease | endometrial cancer (is_implicated_in) | 9.80e-04 | 36 | 160 | 3 | DOID:1380 (is_implicated_in) | |
| Disease | duodenal ulcer | 9.80e-04 | 36 | 160 | 3 | EFO_0004607 | |
| Disease | human immunodeficiency virus infectious disease (is_marker_for) | 9.80e-04 | 36 | 160 | 3 | DOID:526 (is_marker_for) | |
| Disease | complement factor B measurement | 1.03e-03 | 9 | 160 | 2 | EFO_0008096 | |
| Disease | leukocyte immunoglobulin-like receptor subfamily A member 5 measurement | 1.03e-03 | 9 | 160 | 2 | EFO_0801766 | |
| Disease | kallikrein-14 measurement | 1.03e-03 | 9 | 160 | 2 | EFO_0020513 | |
| Disease | late-onset Alzheimers disease | 1.11e-03 | 292 | 160 | 7 | EFO_1001870 | |
| Disease | stroke | 1.16e-03 | 144 | 160 | 5 | EFO_0000712 | |
| Disease | amino acid measurement | PRSS55 CLEC18C LAMB1 WDR25 COL24A1 TENM4 PTPRG PTPRJ SLC22A1 CSMD1 NOTCH1 | 1.23e-03 | 678 | 160 | 11 | EFO_0005134 |
| Disease | DNA repair protein rad51 homolog 1 measurement | 1.28e-03 | 10 | 160 | 2 | EFO_0020330 | |
| Disease | Atypical Hemolytic Uremic Syndrome | 1.28e-03 | 10 | 160 | 2 | C2931788 | |
| Disease | bone morphogenetic protein 7 measurement | 1.28e-03 | 10 | 160 | 2 | EFO_0020187 | |
| Disease | transmembrane glycoprotein NMB measurement | 1.28e-03 | 10 | 160 | 2 | EFO_0008303 | |
| Disease | Fuchs endothelial corneal dystrophy | 1.28e-03 | 10 | 160 | 2 | Orphanet_98974 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| WVTSSVSCGGRHQSP | 71 | P23470 | |
| GCVPSQVWLGASDRS | 551 | A9YTQ3 | |
| WALNPSQCTESGQGI | 176 | P35869 | |
| GATVCSAPSRQELWA | 556 | Q8N944 | |
| CWLVGDVAGSRQPSA | 36 | P59051 | |
| WAPSNTSENCTSGRR | 781 | Q9BYV9 | |
| FQPNDTCIVSGWGRE | 461 | P05156 | |
| SSSTARESCPQRAWG | 451 | A0A096LP49 | |
| ANGTWTGTAPDCTII | 3021 | Q96PZ7 | |
| QADGTWSGIQPTCID | 3196 | Q96PZ7 | |
| PRRFCQSDGTWSGTQ | 3106 | Q7Z408 | |
| QSDGTWSGTQPSCID | 3111 | Q7Z408 | |
| GSTTRTCLPNLTWSG | 3166 | Q7Z408 | |
| SVRQCTANGTWSGTL | 3151 | Q7Z407 | |
| TANGTWSGTLPNCTI | 3156 | Q7Z407 | |
| LTCVGNGTWSGEVPQ | 3271 | Q7Z407 | |
| AGGWTSEGCQLRSSQ | 721 | Q96PE1 | |
| GECTNQKWSVASRPG | 576 | Q9Y2D8 | |
| QKWSVASRPGSQEGC | 581 | Q9Y2D8 | |
| RTGCSGPFQATQLWD | 51 | Q8N2C3 | |
| TCQGARSPESDSIQW | 61 | P12318 | |
| GSSIPCGIGTNISWR | 111 | Q96NL8 | |
| WSQNRTPCAGGAVEF | 36 | Q9BXJ7 | |
| GASNVTCINSRWTGR | 1026 | P08603 | |
| QGQSEGPRTSRNWGS | 2551 | P20930 | |
| STPTEFCRNGGTWEN | 46 | Q96K78 | |
| TSRCGVASGWNPAIL | 171 | Q8TE58 | |
| TLAGRNGVFSWSPCS | 461 | Q8TE57 | |
| WSQCSVTCGEGTQRR | 951 | Q9UKP4 | |
| ISAGTQDSEWGCPTS | 766 | Q6ZS30 | |
| QDSEWGCPTSLEGQL | 771 | Q6ZS30 | |
| CTPDRIWVFGGANQS | 96 | Q7Z6M1 | |
| LQQPRGSQAWVLSCS | 411 | Q6PCD5 | |
| GSQAWVLSCSPSSQG | 416 | Q6PCD5 | |
| LTCDSAPVGSQGTWS | 846 | P20702 | |
| APVGSQGTWSTSCRI | 851 | P20702 | |
| TCRVSGWGTTTSPQV | 156 | Q9UKR3 | |
| GNQQLESLCWGRDSS | 236 | Q15334 | |
| ANITTVWRAQPTEGC | 676 | Q86VD1 | |
| LCSITGGTTPAQWED | 1261 | Q01484 | |
| LRCGVSTPGSAVQWA | 51 | O60500 | |
| NARSSQALGVSWCPA | 6 | Q8N6Y1 | |
| SWSNGNGTASCRVLL | 226 | Q12913 | |
| ESFSCVCPTGWQGQT | 851 | P46531 | |
| QAWPQNSSSCGTEGT | 66 | Q92567 | |
| STCLASGWGSIEPEN | 151 | P06870 | |
| QDSGATLCRNSVLWP | 176 | Q9NYK6 | |
| IIGGHTCTRSSQPWQ | 41 | Q9P0G3 | |
| TECGRNSQPWQVGLF | 26 | Q9UKR0 | |
| LIDGSEPCWQSSGSQ | 2801 | O95714 | |
| EQGTGCWQGPNRSTT | 466 | P14314 | |
| SRLCKSSGQWQTPGA | 61 | P06681 | |
| SSERECQGNGVWSGT | 186 | P06681 | |
| ARGCIWEASNSSGVP | 1876 | O43451 | |
| SQAGWACGRTQGSSP | 631 | Q5VZ46 | |
| PGTARWQCSAVVGRS | 296 | A6NLJ0 | |
| PRWQTCISNTDDALG | 471 | P0DPD6 | |
| PQGTWPSVRSGSCEN | 1216 | Q92824 | |
| EVNCTGSIRQDWPVG | 566 | Q9NYQ8 | |
| SSCPGQLRQRQAASW | 426 | O75564 | |
| WGPDVNNTVCTNERG | 341 | Q8IXI2 | |
| QTEPDAGGRVETWCS | 371 | Q9H5P4 | |
| CETWRTEAPSATGQA | 1706 | P39060 | |
| TRSGGNATLQVDSWP | 1231 | Q9P2S2 | |
| NTTLDQIGTCWPRSA | 41 | Q13324 | |
| RSPASQADGQSGWRC | 391 | Q12986 | |
| PEGWTLNGSAARTCG | 521 | P16581 | |
| TGSCPQGWASDTKLR | 666 | Q9UBG0 | |
| DRCAPNTWQLASGTG | 1066 | P07942 | |
| SREDVSRPCQSWAGS | 146 | Q6X4W1 | |
| SRPCQSWAGSRQGSK | 151 | Q6X4W1 | |
| ASCPWGQEQGARSPS | 16 | Q13087 | |
| QPTCTVGVWIDVGSR | 66 | P31930 | |
| DSCREVTVTPNAAWG | 171 | Q9BQQ3 | |
| NGAAIARCSQPEISW | 226 | Q9NYA4 | |
| GQWAQREGVKSPVCS | 951 | Q9NYA4 | |
| QSDSQCGSPPRGWSE | 331 | Q8IWW6 | |
| EWSQEGCRPGLTSGQ | 131 | Q5T319 | |
| QRAVTGTFCASWTPL | 76 | Q86VX9 | |
| TCAWDSVTVRNGGSP | 2741 | O60494 | |
| SQRSGVLEWCTGTVP | 2761 | Q13315 | |
| AGCSVQPWESLSSNS | 531 | P23508 | |
| PVQWGNCGDTGTRSA | 146 | P83105 | |
| WGQSAKLTCEVRGNP | 336 | Q9BWV1 | |
| CTSNDQERGTWSGPA | 576 | P20023 | |
| STIRCTSDPQGNGVW | 466 | P17927 | |
| STIRCTSDPQGNGVW | 916 | P17927 | |
| IRCTSDPQGNGVWSS | 1821 | P17927 | |
| WSCPEGTLAGNGNST | 26 | P01133 | |
| LAFGNSWQEETRPGC | 1026 | Q9Y6R7 | |
| QGSWASLRSPRVNCT | 1991 | Q9P0X4 | |
| CSITGGTSPAQWEDI | 1246 | Q12955 | |
| DCGSSEPTWLSTNLG | 456 | Q9ULH1 | |
| SGSITCLQNGWSAQP | 376 | Q92496 | |
| GSVTVTCRNKQWSEP | 486 | Q9BXR6 | |
| GGSVLLQSCQASTWR | 2566 | Q0VDD8 | |
| LGPVGRGQWLTSTAC | 2966 | Q0VDD8 | |
| PNNVECTTSGRWSAT | 611 | P16109 | |
| DSTLSCRPSGQWTAV | 681 | P16109 | |
| ALQGITSWGSDPCGR | 221 | O60259 | |
| AAVNEATCTWSGQLP | 286 | Q9BZB8 | |
| NTTTAGVPCQRWDAQ | 296 | P26927 | |
| AQGACVTSTEGAWPR | 31 | A6NH13 | |
| NCVPVAGEATSWSRA | 131 | O00321 | |
| QAAGSNTSWDCSVGP | 146 | O00321 | |
| SQGPQAWDVTTTNCS | 76 | Q8NFL0 | |
| QSPGVAELSQRCGWS | 51 | O15245 | |
| SEGNLTTWLICNRSG | 2811 | Q9NZJ4 | |
| RKACRSASPSSQGWQ | 1406 | Q5VV67 | |
| CVSNGWDPSENARIG | 136 | Q6W0C5 | |
| CQGSLSEARGQVSWA | 361 | Q96AC6 | |
| CTASGSWNDRQPVDS | 321 | P28827 | |
| QACFLSRDGTSVQPW | 726 | Q9Y6K5 | |
| QLNGQLDPSTWCSRA | 416 | Q8IWE5 | |
| STREGQSWQPGAVAT | 1956 | O60469 | |
| AARPSETTLCQVAGW | 491 | P00748 | |
| VCVWRRGTDLSQPSS | 2031 | P0C091 | |
| SQDQTGSGWNFCSIP | 226 | P59025 | |
| LINRSGWTCTQPGGR | 111 | Q7Z5A7 | |
| GWTCTQPGGRIKTTT | 116 | Q7Z5A7 | |
| ECTWTGGQSAPRSLL | 561 | Q9H8W5 | |
| GVQEVSTACTWNGRP | 406 | Q13424 | |
| NGCAVWSTEATFRPG | 186 | Q8N4B1 | |
| TGPWGQCIEDTSVSS | 701 | Q9UPZ6 | |
| GSSRTVWCQRSDGIN | 1486 | Q9UPZ6 | |
| CTQTLRSSAGPTWAQ | 1111 | A0AVI2 | |
| GQDWRGGRQCSNTPD | 116 | A6NJ46 | |
| RTKSWGEQCPETSGT | 201 | P27987 | |
| QPWRPGTVSSGNTCE | 311 | P25391 | |
| VPNSATGSSVRVCWS | 381 | A1L4K1 | |
| SQWQVGGTRSSAVCA | 326 | Q9H3S1 | |
| SCRQARGEWPDSGSS | 251 | Q68DV7 | |
| TTWGDGGENSPCNVV | 101 | O00161 | |
| SSVALNCTAWVVSGP | 26 | Q6IA17 | |
| PATQCGIWVRTSNGG | 41 | Q8NC67 | |
| ETLICLNGTRPSWNG | 326 | Q6UXD5 | |
| LNGTRPSWNGETPSC | 331 | Q6UXD5 | |
| ARVCQSNLAWSGTEP | 301 | P78539 | |
| GKRATTVTGTPCQDW | 491 | P00747 | |
| CPAVWNGSGAVSARQ | 501 | O00186 | |
| TDNGSWNGVSPSCLD | 1731 | Q4LDE5 | |
| GNSTTLCQPDGTWSS | 2416 | Q4LDE5 | |
| EDGTWNGSAPSCISI | 2701 | Q4LDE5 | |
| RVCLANGSWSGATPD | 2871 | Q4LDE5 | |
| RQPSSSSWDSCRGNL | 3551 | Q9NRC6 | |
| RWLSQPLDGSENCSV | 346 | Q8TCG1 | |
| TQLVWATSSQLGCGR | 151 | A5D8T8 | |
| TQLVWATSSQLGCGR | 151 | Q6UXF7 | |
| TQLVWATSSQLGCGR | 151 | Q8NCF0 | |
| SNVQTDCTGDGPWQS | 501 | Q9Y2G3 | |
| HCLNTPRWTSTQTSG | 1621 | Q17RW2 | |
| SGEWAPQSSAVRVTC | 951 | Q15596 | |
| SSWSKTCIGPSQGNG | 451 | O94762 | |
| PIGDWRTQTGCVSTV | 581 | O75443 | |
| CWQVVDGSSSLPNVS | 56 | Q86UV6 | |
| TQGSPQEAGPSWDCR | 916 | O94827 | |
| VAACQTTGTTWDGGP | 766 | A6PVC2 | |
| SAQSSECSEVGPWLQ | 1506 | Q9BX84 | |
| TPSRVCQSSRQWSGS | 301 | O60687 | |
| PIDGVSDWSQGCSLR | 181 | Q8IUC6 | |
| RCSATAQRVAAWTPG | 761 | Q96HA7 | |
| NRGLGNTWTPICNTR | 651 | O75717 | |
| CRLGVSELNPAGSSW | 966 | Q7Z6L1 | |
| QGPESRLGRNSASWC | 536 | Q14258 | |
| DTWASGIRSQPQGCL | 11 | A8MWX3 | |
| QSPSTCSEGLLGWSQ | 711 | Q9C0C2 | |
| GSSAARWSDQGPAQT | 1526 | Q9C0C2 | |
| TSSWSLGESCNRPGL | 6 | Q9BUG6 | |
| SVGWGGTNCETPRAT | 681 | Q6N022 | |
| AGDSCRQGAWTLVSN | 721 | Q99835 | |
| WQVSIQARSEPFCGG | 81 | Q6UWB4 | |
| KTAGWPQRVSSAEQC | 116 | Q0VFX4 | |
| RGGPASQQWTSGVLS | 851 | O15090 | |
| QGDSPCQVWTGESSQ | 136 | A6NK53 | |
| CWQVVDGSSSLPNVS | 56 | Q86UV7 | |
| GSSQQTLWRPEGTQS | 61 | Q7Z403 | |
| AQLGRSDWGSCPSQR | 81 | Q64LD2 | |
| PTSNTEGGWSCSLAE | 5111 | Q5T4S7 | |
| DWSTNSDSGPVTQNC | 221 | Q9Y6X0 | |
| RLQASGAGTWCVDPA | 1116 | P01266 | |
| QSCTVQVTQAPGGWE | 256 | Q06418 | |
| GPSTGSTAETQCRNW | 31 | Q5T200 | |
| GNAQAPCWGRSSSST | 551 | Q9UPQ9 | |
| ANSNVTLRCWTPARG | 41 | B6A8C7 | |
| QARSTAECWPEGGSV | 376 | Q9H0D2 | |
| NWTGEPAAINSCSLS | 701 | A6NNM8 | |
| EEWQQCSRTCGGGTQ | 766 | P82987 | |
| WDSSRTPIIGSCGTQ | 3186 | Q14789 | |
| PRGVNWCERTTLSNG | 661 | P01130 |